☰

Philip D. Harvey - Publications

Affiliations: 
2010- Psychiatry University of Miami Miller School of Medicine, Miami, FL, United States 
Area:
Severe mental illness; technology; genomics
Tree Info Grants Similar researchers PubMed Report error

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bigdeli TB, Fanous AH, Li Y, Rajeevan N, Sayward F, Genovese G, Gupta R, Radhakrishnan K, Malhotra AK, Sun N, Lu Q, Hu Y, Li B, Chen Q, Mane S, ... ... Harvey PD, et al. Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans. Schizophrenia Bulletin. PMID 33169155 DOI: 10.1016/J.Biopsych.2020.02.468  0.415
2020 Harvey PD, Forero DB, Ahern LB, Tiberica L, Kallestrup P, Czaja SJ. The Computerized Functional Skills Assessment and Training Program: Sensitivity to Global Cognitive Impairment, Correlations With Cognitive Abilities, and Factor Structure. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 32980252 DOI: 10.1016/J.Jagp.2020.08.019  0.598
2020 Harvey PD, Horan WP, Atkins AS, Stevens H, Welch M, Yuan J, Patterson TL, Narasimhan M, Keefe RSE. Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures. Schizophrenia Research. PMID 32928621 DOI: 10.1016/J.Schres.2020.08.010  0.838
2020 Miller BJ, Pikalov A, Siu CO, Tocco M, Tsai J, Harvey PD, Newcomer JW, Loebel A. Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia. Comprehensive Psychiatry. 102: 152195. PMID 32896775 DOI: 10.1016/J.Comppsych.2020.152195  0.501
2020 Jones MT, Harvey PD. Major Neuropsychological Impairments in Schizophrenia Patients: Clinical Implications. Current Psychiatry Reports. 22: 59. PMID 32886232 DOI: 10.1007/S11920-020-01181-0  0.83
2020 Strassnig M, Jones MT, Pinkham A, Penn D, Jarskog LF, Harvey PD. Depression, hostility, attributional biases, and paranoia in schizophrenia and healthy controls: intercorrelations and associations with self-assessment of social functioning. Psychiatry Research. 293: 113388. PMID 32866794 DOI: 10.1016/J.Psychres.2020.113388  0.827
2020 Gould F, Harvey PD, Hodgins G, Jones MT, Michopoulos V, Maples-Keller J, Rothbaum BO, Rothbaum AO, Ressler KJ, Nemeroff CB. Prior trauma-related experiences predict the development of posttraumatic stress disorder after a new traumatic event. Depression and Anxiety. PMID 32789992 DOI: 10.1002/Da.23084  0.703
2020 Keefe RSE, Green MF, Harvey PD. Requisite Skills and the Meaningful Measurement of Cognition. Jama Psychiatry. PMID 32639514 DOI: 10.1001/Jamapsychiatry.2020.1618  0.576
2020 Deste G, Vita A, Nibbio G, Penn DL, Pinkham AE, Harvey PD. Autistic Symptoms and Social Cognition Predict Real-World Outcomes in Patients With Schizophrenia. Frontiers in Psychiatry. 11: 524. PMID 32581892 DOI: 10.3389/Fpsyt.2020.00524  0.777
2020 Harvey PD. An Array of Studies Addressing Cognition and Cognitively Defined Neuropsychiatric Conditions: Many More Connections Than You Might Think. The American Journal of Psychiatry. 177: 491-496. PMID 32475142 DOI: 10.1176/Appi.Ajp.2020.20040407  0.467
2020 Goldberg TE, Harvey PD, Devanand DP, Keefe RSE, Gomar JJ. Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum. The Journal of Prevention of Alzheimer's Disease. 7: 179-183. PMID 32463071 DOI: 10.14283/jpad.2019.51  0.483
2020 Jones MT, Strassnig MT, Harvey PD. Emerging 5-HT receptor antagonists for the treatment of Schizophrenia. Expert Opinion On Emerging Drugs. PMID 32449404 DOI: 10.1080/14728214.2020.1773792  0.832
2020 Klein HS, Springfield CR, Bass E, Ludwig K, Penn DL, Harvey PD, Pinkham AE. Measuring mentalizing: A comparison of scoring methods for the hinting task. International Journal of Methods in Psychiatric Research. e1827. PMID 32385868 DOI: 10.1002/Mpr.1827  0.701
2020 Moore RC, Depp CA, Harvey PD, Pinkham AE. Implementing a Protocol to Assess Real-Time Mental Health Challenges of COVID-19 in Individuals with Serious Mental Illnesses. Jmir Research Protocols. PMID 32365043 DOI: 10.2196/19203  0.699
2020 Foti D, Perlman G, Bromet EJ, Harvey PD, Hajcak G, Mathalon DH, Kotov R. Pathways from performance monitoring to negative symptoms and functional outcomes in psychotic disorders. Psychological Medicine. 1-11. PMID 32317045 DOI: 10.1017/S0033291720000768  0.408
2020 Halverson TF, Hajdúk M, Pinkham AE, Harvey PD, Jarskog LF, Nye L, Penn DL. Psychometric properties of the Observable Social Cognition Rating Scale (OSCARS): Self-report and informant-rated social cognitive abilities in schizophrenia. Psychiatry Research. 286: 112891. PMID 32145477 DOI: 10.1016/J.Psychres.2020.112891  0.751
2020 Harvey PD, Tibiriçá L, Kallestrup P, Czaja SJ. A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills. Journal of Visualized Experiments : Jove. PMID 32116309 DOI: 10.3791/60330  0.517
2020 Aslan M, Radhakrishnan K, Rajeevan N, Sueiro M, Goulet JL, Li Y, Depp C, Concato J, Harvey PD. Suicidal ideation, behavior, and mortality in male and female US veterans with severe mental illness. Journal of Affective Disorders. 267: 144-152. PMID 32063566 DOI: 10.1016/J.Jad.2020.02.022  0.54
2020 Harvey PD, Bowie CR, McDonald S, Podhorna J. Evaluation of the Efficacy of BI 425809 Pharmacotherapy in Patients with Schizophrenia Receiving Computerized Cognitive Training: Methodology for a Double-blind, Randomized, Parallel-group Trial. Clinical Drug Investigation. PMID 32036587 DOI: 10.1007/S40261-020-00893-8  0.689
2020 Saltz SB, Rozon M, Pogge DL, Harvey PD. Cyberbullying and Its Relationship to Current Symptoms and History of Early Life Trauma: A Study of Adolescents in an Acute Inpatient Psychiatric Unit. The Journal of Clinical Psychiatry. 81. PMID 31944065 DOI: 10.4088/Jcp.18M12170  0.31
2020 Harvey PD, Balzer AM, Kotwicki RJ. Training engagement, baseline cognitive functioning, and cognitive gains with computerized cognitive training: A cross-diagnostic study. Schizophrenia Research. Cognition. 19: 100150. PMID 31832340 DOI: 10.1016/J.Scog.2019.100150  0.403
2020 Jones MT, Deckler E, Laurrari C, Jarskog LF, Penn DL, Pinkham AE, Harvey PD. Confidence, performance, and accuracy of self-assessment of social cognition: A comparison of schizophrenia patients and healthy controls. Schizophrenia Research. Cognition. 19: 002-2. PMID 31832336 DOI: 10.1093/Schbul/Sbz021.204  0.861
2020 Harvey PD, Isner EC. Cognition, Social Cognition, and Functional Capacity in Early-Onset Schizophrenia. Child and Adolescent Psychiatric Clinics of North America. 29: 171-182. PMID 31708046 DOI: 10.1016/J.Chc.2019.08.008  0.539
2020 Fundora-Trujillo C, Cruz M, Barone K, Penn DL, Pinkham A, Harvey P. S223. DETERMINANTS OF SUSTAINED UNEMPLOYMENT IN FORMERLY EMPLOYED SCHIZOPHRENIA PATIENTS Schizophrenia Bulletin. 46: S123-S124. DOI: 10.1093/Schbul/Sbaa031.289  0.739
2020 Vanover K, Davis R, Durgam S, Huo J, Mates S, Satlin A, Harvey PD. S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF SCHIZOPHRENIA SYMPTOMS ASSOCIATED WITH SOCIAL FUNCTIONING: POST HOC ANALYSIS OF AN ACUTE PLACEBO- AND ACTIVE-CONTROLLED TRIAL Schizophrenia Bulletin. 46: S123-S123. DOI: 10.1093/Schbul/Sbaa031.287  0.476
2020 Bigdeli T, Fanous A, Rajeevan N, Sayward F, Li Y, Brophy M, Pyarajan S, Gleason T, Przygodszki R, Gaziano M, O’Leary T, Muralidhar S, Huang G, Concato J, Siever L, ... ... Harvey P, et al. S173. Genome-Wide Association Studies Of Schizophrenia And Bipolar Disorder In A Diverse Cohort Of Us Veterans Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa031.239  0.412
2020 Lindenmayer J, Khan A, Harvey P, Keefe R, Liharska L, Yavorsky C, Seddo M. M120. IMPAIRED CLINICAL INSIGHT AS A PREDICTOR OF RELAPSE IN SCHIZOPHRENIA Schizophrenia Bulletin. 46: S180-S181. DOI: 10.1093/Schbul/Sbaa030.432  0.609
2020 Parrish E, Depp C, Moore RC, Harvey PD, Holden J, Swendsen J, Granholm E. O1.6. AFFECTIVE DETERMINANTS OF LIFE-SPACE THROUGH GPS AND ECOLOGICAL MOMENTARY ASSESSMENT IN SCHIZOPHRENIA: WHAT GETS PEOPLE OUT OF THE HOUSE? Schizophrenia Bulletin. 46: S3-S3. DOI: 10.1093/Schbul/Sbaa028.005  0.787
2020 Pinkham AE, Ackerman RA, Depp CA, Harvey PD, Moore RC. A Longitudinal Investigation of the Effects of the COVID-19 Pandemic on the Mental Health of Individuals with Pre-existing Severe Mental Illnesses Psychiatry Research. 294: 113493. DOI: 10.1016/j.psychres.2020.113493  0.601
2020 Strassnig M, Harvey P, Depp C, Granholm E. Smartphone-Based Assessment of Real-World Sedentary Behavior in Schizophrenia Biological Psychiatry. 87: S339-S340. DOI: 10.1016/J.Biopsych.2020.02.871  0.81
2020 O'Donoghue EM, Pogge DL, Stokes JM, Harvey PD. Cognitive Correlates of Early Life Abuse in Adolescent Psychiatric Inpatients Biological Psychiatry. 87: S262. DOI: 10.1016/J.Biopsych.2020.02.677  0.358
2020 Miller M, Pinkham A, Depp C, Moore R, Harvey P. Self-Assessments of Cognitive Performance in Schizophrenia: The Role of Impaired Momentary Judgement Biological Psychiatry. 87: S220. DOI: 10.1016/J.Biopsych.2020.02.572  0.844
2020 Harvey P, Pinkham A, Depp C, Granholm E. Immediate Accuracy of Judgments of Memory Performance Examined With Ecological Momentary Assessment Across Variable Levels of Objective Difficulty: Context and Symptom Correlates Biological Psychiatry. 87: S184-S185. DOI: 10.1016/J.Biopsych.2020.02.484  0.735
2020 Bigdeli T, Fanous A, Li Y, Rajeevan N, Sayward F, Zhao H, Brophy M, Pyarajan S, O'Leary T, Gleason T, Przygodszki R, Muralidhar S, Gaziano JM, Concato J, Siever L, ... ... Harvey PD, et al. Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans Biological Psychiatry. 87: S178. DOI: 10.1016/j.biopsych.2020.02.468  0.301
2020 Perez M, Tercero B, Penn D, Pinkham A, Harvey P. Confidence as a Predictor of Social and Neurocognitive Performance in Schizophrenia Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.414  0.74
2020 Tercero B, Perez M, Penn D, Pinkham A, Harvey P. A Cross-Sectional Comparison of Overconfidence in Social Performance Between Healthy Individuals and Schizophrenic Patients Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.358  0.658
2019 Harvey PD, Sun N, Bigdeli TB, Fanous AH, Aslan M, Malhotra AK, Lu Q, Hu Y, Li B, Chen Q, Mane S, Miller P, Rajeevan N, Sayward F, Cheung KH, et al. Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 31872970 DOI: 10.1002/ajmg.b.32775  0.383
2019 Muralidharan A, Finch A, Bowie CR, Harvey PD. Older versus middle-aged adults with schizophrenia: Executive functioning and community outcomes. Schizophrenia Research. PMID 31806528 DOI: 10.1016/J.Schres.2019.11.001  0.604
2019 Harvey PD, Nakamura H, Miura S. Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study. Neuropsychopharmacology Reports. PMID 31788985 DOI: 10.1002/npr2.12089  0.34
2019 Deste G, Vita A, Penn DL, Pinkham AE, Nibbio G, Harvey PD. Autistic symptoms predict social cognitive performance in patients with schizophrenia. Schizophrenia Research. PMID 31780344 DOI: 10.1016/J.Schres.2019.11.008  0.782
2019 Harvey PD. Domains of cognition and their assessment
. Dialogues in Clinical Neuroscience. 21: 227-237. PMID 31749647 DOI: 10.31887/Dcns.2019.21.3/Pharvey  0.401
2019 Oliveri LN, Awerbuch AW, Jarskog LF, Penn DL, Pinkham A, Harvey PD. Depression predicts self assessment of social function in both patients with schizophrenia and healthy people. Psychiatry Research. 112681. PMID 31740212 DOI: 10.1016/J.Psychres.2019.112681  0.711
2019 Depp CA, Bashem J, Moore RC, Holden JL, Mikhael T, Swendsen J, Harvey PD, Granholm EL. GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study. Npj Digital Medicine. 2: 108. PMID 31728415 DOI: 10.1038/s41746-019-0182-1  0.772
2019 Ludwig KA, Nye LN, Simmons GL, Jarskog LF, Pinkham AE, Harvey PD, Penn DL. Correlates of loneliness among persons with psychotic disorders. Social Psychiatry and Psychiatric Epidemiology. PMID 31667560 DOI: 10.1007/S00127-019-01789-5  0.702
2019 Pinkham AE, Morrison KE, Penn DL, Harvey PD, Kelsven S, Ludwig K, Sasson NJ. Comprehensive comparison of social cognitive performance in autism spectrum disorder and schizophrenia. Psychological Medicine. 1-9. PMID 31576783 DOI: 10.1017/S0033291719002708  0.748
2019 Murthy NV, Xu R, Zhong W, Harvey PD. Using self-reported vocational functioning measures to identify employed patients with impaired functional capacity in major depressive disorder. Journal of Affective Disorders. 260: 550-556. PMID 31539692 DOI: 10.1016/J.Jad.2019.09.025  0.43
2019 Granholm E, Holden JL, Mikhael T, Link PC, Swendsen J, Depp C, Moore RC, Harvey PD. What Do People With Schizophrenia Do All Day? Ecological Momentary Assessment of Real-World Functioning in Schizophrenia. Schizophrenia Bulletin. PMID 31504955 DOI: 10.1093/Schbul/Sbz070  0.799
2019 Harvey PD, Saoud JB, Luthringer R, Moroz S, Blazhevych Y, Stefanescu C, Davidson M. Effects of Roluperidone (MIN-101) on two dimensions of the negative symptoms factor score: Reduced emotional experience and reduced emotional expression. Schizophrenia Research. PMID 31488314 DOI: 10.1016/J.Schres.2019.08.029  0.386
2019 Jacobson W, Zhong W, Nomikos GG, Christensen MC, Kurre Olsen C, Harvey PD. Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis. Current Medical Research and Opinion. 1. PMID 31422713 DOI: 10.1080/03007995.2019.1657692  0.417
2019 Strassnig MT, Nascimento V, Deckler E, Harvey PD. Pharmacological treatment of violence in schizophrenia. Cns Spectrums. 1-9. PMID 31342892 DOI: 10.1017/S1092852919001226  0.705
2019 Jones MT, Harvey PD. Neurocognition and social cognition training as treatments for violence and aggression in people with severe mental illness. Cns Spectrums. 1-9. PMID 31248468 DOI: 10.1017/S1092852919001214  0.795
2019 Harvey PD, Khan A, Atkins A, Walker TM, Keefe RSE. Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS). Schizophrenia Research. PMID 31196736 DOI: 10.1016/J.Schres.2019.05.040  0.796
2019 Harvey PD, Jones MT. Functional deficits in attenuated psychosis syndrome and related conditions: Current and future treatment options. Schizophrenia Research. Cognition. 17: 100152. PMID 31193274 DOI: 10.1016/J.Scog.2019.100152  0.777
2019 Harvey PD, Deckler E, Jones MT, Jarskog LF, Penn DL, Pinkham AE. Autism symptoms, depression, and active social avoidance in schizophrenia: Association with self-reports and informant assessments of everyday functioning. Journal of Psychiatric Research. 115: 36-42. PMID 31102902 DOI: 10.1016/J.Jpsychires.2019.05.010  0.84
2019 Harvey PD, Strassnig MT. Cognition and disability in schizophrenia: cognition-related skills deficits and decision-making challenges add to morbidity. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 165-167. PMID 31059625 DOI: 10.1002/Wps.20647  0.747
2019 Harvey PD, Nakamura H, Murasaki M. Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8-week, double-blind, multicenter, randomized controlled study. Neuropsychopharmacology Reports. PMID 31041855 DOI: 10.1002/npr2.12057  0.308
2019 Burdick KE, Millett CE, Del Mar Bonnín C, Bowie C, Carvalho AF, Eyler LT, Gallagher P, Harvey P, Kessing LV, Lafer B, Langenecker SA, Lewandowski KE, López-Jaramillo C, Marshall DF, Martinez-Aran A, et al. The International Consortium Investigating Neurocognition in Bipolar Disorder (ICONIC-BD). Bipolar Disorders. PMID 30720913 DOI: 10.1111/Bdi.12748  0.665
2019 Harvey PD. Smoking Cannabis and Acquired Impairments in Cognition: Starting Early Seems Like a Really Bad Idea. The American Journal of Psychiatry. 176: 90-91. PMID 30704281 DOI: 10.1176/Appi.Ajp.2018.18121348  0.357
2019 Silberstein J, Harvey PD. Cognition, social cognition, and Self-assessment in schizophrenia: prediction of different elements of everyday functional outcomes. Cns Spectrums. 1-6. PMID 30683165 DOI: 10.1017/S1092852918001414  0.84
2019 Harvey PD, Khan A, Atkins A, Keefe RS. Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes. Psychiatry Research. PMID 30679049 DOI: 10.1016/J.Psychres.2019.01.045  0.76
2019 McClure MM, Graff F, Triebwasser J, Perez-Rodriguez M, Rosell DR, Koenigsberg H, Hazlett EA, Siever LJ, Harvey PD, New AS. Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder. The American Journal of Psychiatry. appiajp201818030349. PMID 30654644 DOI: 10.1176/Appi.Ajp.2018.18030349  0.746
2019 McIntyre RS, Anderson N, Baune BT, Brietzke E, Burdick K, Fossati P, Gorwood P, Harmer C, Harrison J, Harvey P, Mansur RB, Medalia A, Miskowiak K, Ramey T, Rong C, et al. Expert Consensus on Screening and Assessment of Cognition in Psychiatry. Cns Spectrums. 1-9. PMID 30642417 DOI: 10.1017/S1092852918001189  0.429
2019 Harvey PD. Introduction to special issue "4th biennial mt. Sinai conference on cognition in schizophrenia" Schizophrenia Research. 43: 1-2. PMID 10828409 DOI: 10.1016/S0920-9964(99)00181-4  0.502
2019 Harvey PD, Strassnig MT, Silberstein J. Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment Journal of Experimental Psychopathology. 10: 204380871986569. DOI: 10.1177/2043808719865693  0.856
2019 Harvey PD, Deckler E, Jones MT, Jarskog LF, Penn DL, Pinkham AE. Depression and reduced emotional experience in schizophrenia: Correlations with self-reported and informant-rated everyday social functioning Journal of Experimental Psychopathology. 10: 204380871982931. DOI: 10.1177/2043808719829313  0.82
2019 Strassnig M, Harvey P, Holden J, Mikhael T, Depp C, Granholm E. O6.6. REAL WORLD SEDENTARY BEHAVIOR AND ACTIVITY LEVELS IN PATIENTS WITH SCHIZOPHRENIA AND CONTROLS DERIVED FROM ECOLOGICAL MOMENTARY ASSESSMENT Schizophrenia Bulletin. 45: S178-S178. DOI: 10.1093/Schbul/Sbz021.222  0.797
2019 Harvey P, Khan A, Atkins A, Keefe R. O5.7. VIRTUAL REALITY FUNCTIONAL CAPACITY ASSESSMENT IN PATIENTS WITH SCHIZOPHRENIA: CORRELATES OF PERFORMANCE OF SOLITARY AND SOCIALLY RELEVANT TASKS Schizophrenia Bulletin. 45: S175-S175. DOI: 10.1093/Schbul/Sbz021.216  0.757
2019 Harvey P, Aslan M, Sun N, Zhao H, Concato J. S93. GENOMICS OF SUICIDAL IDEATION AND BEHAVIOR IN VETERANS WITH SCHIZOPHRENIA AND BIPOLAR ILLNESS Schizophrenia Bulletin. 45: S342-S342. DOI: 10.1093/Schbul/Sbz020.638  0.393
2019 Awerbuch A, Oliveri L, Penn DL, Pinkham A, Harvey P. S43. SADDER BUT WISER: DEPRESSION OUTWEIGHS SEX AND SCHIZOPHRENIA IN SELF ASSESSMENT OF INTERPERSONAL FUNCTIONING Schizophrenia Bulletin. 45: S322-S323. DOI: 10.1093/Schbul/Sbz020.588  0.716
2019 McDonald S, Podhorna J, Huang S, Harvey P. S30. COMBINING PHARMACOTHERAPY OF BI 425809 WITH COMPUTERIZED COGNITIVE TRAINING IN PATIENTS WITH SCHIZOPHRENIA: A RANDOMIZED TRIAL METHODOLOGY Schizophrenia Bulletin. 45: S316-S317. DOI: 10.1093/Schbul/Sbz020.575  0.474
2019 Nucifora F, Baker K, Stricklin A, Cuerdo A, Parke K, DuBois S, Nucifora L, Margolis R, Sawa A, Harvey P. F53. IMPROVED FUNCTIONAL CAPACITY AND COGNITIVE PERFORMANCE IN CLOZAPINE RESPONDERS COMPARED TO NON-RESPONDERS Schizophrenia Bulletin. 45: S275-S276. DOI: 10.1093/Schbul/Sbz018.465  0.395
2019 Zhand N, Attwood DG, Harvey PD. Glutamate modulators for treatment of schizophrenia Personalized Medicine in Psychiatry. 15: 1-12. DOI: 10.1016/J.Pmip.2019.02.001  0.464
2019 Gomar JJ, Harvey PD, Devanand DP, Keefe RS, Goldberg TE. P2-463: DEVELOPMENT OF AN UPSA SHORT FORM FOR USE IN LONGITUDINAL STUDIES IN THE EARLY ALZHEIMER'S DISEASE SPECTRUM Alzheimer's & Dementia. 15: P794-P794. DOI: 10.1016/J.Jalz.2019.06.2870  0.443
2019 Miller B, Pikalov A, Siu C, Tocco M, Tsai J, Harvey P, Loebel A. Inflammatory markers and cognitive performance in patients with schizophrenia treated with lurasidone European Neuropsychopharmacology. 29: S416-S417. DOI: 10.1016/J.Euroneuro.2018.11.631  0.521
2019 Harvey P, Sun N, Lu Q, Hu Y, Li B, Chen Q, Aslan M, Radhakrishnan K, Cheung K, Li Y, Sayward F, Rajeevan N, Zhao H, Gaziano M, Concato J. Genetics Of Cognitive Function In Schizophrenia And Bipolar Disorder European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.332  0.537
2018 Silberstein J, Harvey PD. Impaired introspective accuracy in schizophrenia: an independent predictor of functional outcomes. Cognitive Neuropsychiatry. 1-12. PMID 30477401 DOI: 10.1080/13546805.2018.1549985  0.862
2018 Harvey PD, Deckler E, Jarsksog LF, Penn DL, Pinkham AE. Predictors of social functioning in patients with higher and lower levels of reduced emotional experience: Social cognition, social competence, and symptom severity. Schizophrenia Research. PMID 30446271 DOI: 10.1093/Schbul/Sbz020.668  0.726
2018 Depp CA, Villa J, Schembari BC, Harvey PD, Pinkham A. Social cognition and short-term prediction of suicidal ideation in schizophrenia. Psychiatry Research. 270: 13-19. PMID 30243127 DOI: 10.1016/J.Psychres.2018.09.005  0.77
2018 Muralidharan A, Harvey PD, Bowie CR. Associations of Age and Gender with Negative Symptom Factors and Functioning Among Middle-Aged and Older Adults with Schizophrenia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 30236901 DOI: 10.1016/J.Jagp.2018.07.006  0.623
2018 Harvey PD, McGurk SR, Mahncke H, Wykes T. Controversies in Computerized Cognitive Training. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 30197048 DOI: 10.1016/J.Bpsc.2018.06.008  0.513
2018 Lanser I, Browne J, Pinkham AE, Harvey PD, Jarskog LF, Penn DL. Evaluating social skill in individuals with schizophrenia with the brief impression questionnaire (BIQ). Psychiatry Research. 269: 38-44. PMID 30145299 DOI: 10.1016/J.Psychres.2018.08.047  0.773
2018 Deckler E, Hodgins GE, Pinkham AE, Penn DL, Harvey PD. Social Cognition and Neurocognition in Schizophrenia and Healthy Controls: Intercorrelations of Performance and Effects of Manipulations Aimed at Increasing Task Difficulty. Frontiers in Psychiatry. 9: 356. PMID 30131729 DOI: 10.3389/Fpsyt.2018.00356  0.731
2018 Gould F, Dunlop BW, Rosenthal JB, Iosifescu DV, Mathew SJ, Neylan TC, Rothbaum BO, Nemeroff CB, Harvey PD. Temporal Stability of Cognitive Functioning and Functional Capacity in Women with Posttraumatic Stress Disorder. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 30124744 DOI: 10.1093/Arclin/Acy064  0.449
2018 Pinkham AE, Klein HS, Hardaway GB, Kemp KC, Harvey PD. Neural correlates of social cognitive introspective accuracy in schizophrenia. Schizophrenia Research. PMID 30077432 DOI: 10.1016/J.Schres.2018.07.001  0.698
2018 Harvey PD. The Course of Cognition and Functioning in Patients at Ultrahigh Risk of Developing Psychosis: The Roles of Remission and Persistent Nonconverting Symptoms. Jama Psychiatry. PMID 30046829 DOI: 10.1001/Jamapsychiatry.2018.1618  0.443
2018 Harvey PD. Combining training leads to better results: Implications for clinical delivery of computerized cognitive and social cognitive training. Schizophrenia Research. PMID 30029832 DOI: 10.1016/J.Schres.2018.07.021  0.372
2018 Strassnig M, Bowie C, Pinkham AE, Penn D, Twamley EW, Patterson TL, Harvey PD. Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia? Journal of Psychiatric Research. 104: 124-129. PMID 30029051 DOI: 10.1016/J.Jpsychires.2018.06.018  0.859
2018 Hajdúk M, Klein HS, Harvey PD, Penn DL, Pinkham AE. Paranoia and interpersonal functioning across the continuum from healthy to pathological - Network analysis. The British Journal of Clinical Psychology. PMID 30028025 DOI: 10.1111/Bjc.12199  0.721
2018 Buck B, Hester NR, Pinkham A, Harvey PD, Jarskog LF, Penn DL. The bias toward intentionality in schizophrenia: Automaticity, context, and relationships to symptoms and functioning. Journal of Abnormal Psychology. 127: 503-512. PMID 30010368 DOI: 10.1037/Abn0000360  0.76
2018 Hajdúk M, Harvey PD, Penn DL, Pinkham AE. Social cognitive impairments in individuals with schizophrenia vary in severity. Journal of Psychiatric Research. 104: 65-71. PMID 29982084 DOI: 10.1016/J.Jpsychires.2018.06.017  0.763
2018 Keefe RSE, Harvey PD, Khan A, Saoud JB, Staner C, Davidson M, Luthringer R. Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial. The Journal of Clinical Psychiatry. 79. PMID 29873956 DOI: 10.4088/Jcp.17M11753  0.677
2018 Moradi H, Harvey PD, Helldin L. Correlates of risk factors for reduced life expectancy in schizophrenia: Is it possible to develop a predictor profile? Schizophrenia Research. PMID 29859858 DOI: 10.1016/J.Schres.2018.05.035  0.513
2018 Bowie CR, Best MW, Depp C, Mausbach BT, Patterson TL, Pulver AE, Harvey PD. Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis. Bipolar Disorders. PMID 29777563 DOI: 10.1111/Bdi.12654  0.813
2018 Harvey PD, Posner K, Rajeevan N, Yershova KV, Aslan M, Concato J. Suicidal ideation and behavior in US veterans with schizophrenia or bipolar disorder. Journal of Psychiatric Research. 102: 216-222. PMID 29698922 DOI: 10.1016/J.Jpsychires.2018.04.014  0.412
2018 Silberstein JM, Pinkham AE, Penn DL, Harvey PD. Self-assessment of social cognitive ability in schizophrenia: Association with social cognitive test performance, informant assessments of social cognitive ability, and everyday outcomes. Schizophrenia Research. PMID 29673732 DOI: 10.1016/J.Biopsych.2018.02.1089  0.84
2018 Villa J, Pinkham AE, Kaufmann CN, Granholm E, Harvey PD, Depp CA. Interpersonal beliefs related to suicide and facial emotion processing in psychotic disorders. Journal of Psychiatric Research. 100: 107-112. PMID 29514121 DOI: 10.1016/J.Jpsychires.2018.02.016  0.791
2018 Strassnig M, Kotov R, Fochtmann L, Kalin M, Bromet EJ, Harvey PD. Associations of independent living and labor force participation with impairment indicators in schizophrenia and bipolar disorder at 20-year follow-up. Schizophrenia Research. PMID 29472164 DOI: 10.1016/J.Schres.2018.02.009  0.733
2018 Granholm E, Harvey PD. Social Skills Training for Negative Symptoms of Schizophrenia. Schizophrenia Bulletin. PMID 29315427 DOI: 10.1093/Schbul/Sbx184  0.649
2018 Harvey PD, Goldman R, Tocco M, Deng L, Cucchiaro J, Loebel A. S73. EFFECT OF LURASIDONE ON COGNITION IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY Schizophrenia Bulletin. 44: S353-S353. DOI: 10.1093/Schbul/Sby018.860  0.467
2018 Harvey P, Vanover K, Davis R, Penn D, Pinkham A. F250. DEPRESSION IN SCHIZOPHRENIA: CORRELATIONS WITH OBJECTIVE AND SUBJECTIVE QUALITY OF LIFE OUTCOMES Schizophrenia Bulletin. 44: S320-S320. DOI: 10.1093/Schbul/Sby017.781  0.681
2018 Pikalov A, Miller B, Siu C, Tocco M, Tsai J, Harvey P, Loebel A. F60. INFLAMMATORY MARKERS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH LURASIDONE Schizophrenia Bulletin. 44: S242-S243. DOI: 10.1093/schbul/sby017.591  0.38
2018 Khan A, Liharska L, Harvey P, Atkins A, Keefe R, Ulshen D. T111. PANSS NEGATIVE SYMPTOM DIMENSIONS ACROSS GEOGRAPHICAL REGIONS: IMPLICATIONS FOR SOCIAL, LINGUISTIC AND CULTURAL CONSISTENCY Schizophrenia Bulletin. 44: S159-S159. DOI: 10.1093/Schbul/Sby016.387  0.688
2018 Harvey P, Muralidharan A. 24.4 COGNITION AND COMMUNICATION AS DETERMINANTS OF ADAPTIVE DEFICITS IN LATE LIFE SCHIZOPHRENIA Schizophrenia Bulletin. 44: S40-S40. DOI: 10.1093/Schbul/Sby014.099  0.503
2018 Harvey PD, Goldman RS, Tocco M, Deng L, Cucchiaro JB, Loebel A. 6.16 Effect of Lurasidone on Neurocognitive Performance in Adolescents With Schizophrenia: Results of a Two-Year Open-Label Extension Study Journal of the American Academy of Child & Adolescent Psychiatry. 57: S254-S255. DOI: 10.1016/J.Jaac.2018.09.380  0.405
2018 Strassnig M, Pinkham A, Penn D, Harvey P. T251. Severity of Impairment in Cognition and Negative Symptoms and Their Relation With Functional Deficits Biological Psychiatry. 83: S227. DOI: 10.1016/J.Biopsych.2018.02.588  0.814
2017 Khan A, Liharska L, Harvey PD, Atkins A, Ulshen D, Keefe RSE. Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency. Innovations in Clinical Neuroscience. 14: 30-40. PMID 29410935  0.699
2017 Harvey PD, Siu CO, Loebel AD. Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR. Innovations in Clinical Neuroscience. 14: 23-29. PMID 29410934  0.329
2017 Harvey PD, Khan A, Keefe RSE. Using the Positive and Negative Syndrome Scale (PANSS) to Define Different Domains of Negative Symptoms: Prediction of Everyday Functioning by Impairments in Emotional Expression and Emotional Experience. Innovations in Clinical Neuroscience. 14: 18-22. PMID 29410933  0.487
2017 Harvey PD, Sand M. Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia. Frontiers in Psychiatry. 8: 177. PMID 28993740 DOI: 10.3389/Fpsyt.2017.00177  0.381
2017 Pinkham AE, Harvey PD, Penn DL. Social Cognition Psychometric Evaluation: Results of the Final Validation Study. Schizophrenia Bulletin. PMID 28981848 DOI: 10.1093/Schbul/Sbx117  0.704
2017 Crocco EA, Loewenstein DA, Curiel RE, Alperin N, Czaja SJ, Harvey PD, Sun X, Lenchus J, Raffo A, Peñate A, Melo J, Sang L, Valdivia R, Cardenas K. A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment (PreMCI) and the relationship to biological markers of Alzheimer's disease. Journal of Psychiatric Research. 96: 33-38. PMID 28957712 DOI: 10.1016/J.Jpsychires.2017.08.015  0.805
2017 Strassnig M, Rosenfeld A, Harvey PD. Tardive dyskinesia: motor system impairments, cognition and everyday functioning. Cns Spectrums. 1-8. PMID 28877766 DOI: 10.1017/S1092852917000542  0.733
2017 Muralidharan A, Finch A, Bowie CR, Harvey PD. Thought, language, and communication deficits and association with everyday functional outcomes among community-dwelling middle-aged and older adults with schizophrenia. Schizophrenia Research. PMID 28778553 DOI: 10.1016/J.Schres.2017.07.017  0.661
2017 Strassnig M, Cornacchio D, Harvey PD, Kotov R, Fochtmann L, Bromet EJ. Health status and mobility limitations are associated with residential and employment status in schizophrenia and bipolar disorder. Journal of Psychiatric Research. 94: 180-185. PMID 28743064 DOI: 10.1016/J.Jpsychires.2017.07.011  0.733
2017 Villa J, Choi J, Kangas JL, Kaufmann CN, Harvey PD, Depp CA. Associations of suicidality with cognitive ability and cognitive insight in outpatients with Schizophrenia. Schizophrenia Research. PMID 28655480 DOI: 10.1016/J.Schres.2017.06.013  0.66
2017 Keefe RSE, Davis VG, Harvey PD, Atkins AS, Haig GM, Hagino O, Marder S, Hilt DC, Umbricht D. Placebo Response and Practice Effects in Schizophrenia Cognition Trials. Jama Psychiatry. PMID 28636694 DOI: 10.1001/Jamapsychiatry.2017.1574  0.786
2017 Vella L, Patterson TL, Harvey PD, McClure MM, Mausbach BT, Taylor MJ, Twamley EW. Exploratory analysis of normative performance on the UCSD Performance-Based Skills Assessment-Brief. Psychiatry Research. 256: 150-155. PMID 28633056 DOI: 10.1016/J.Psychres.2017.06.025  0.72
2017 Strassnig M, Kotov R, Cornaccio D, Fochtmann L, Harvey PD, Bromet EJ. Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis. Bipolar Disorders. PMID 28574189 DOI: 10.1111/Bdi.12505  0.701
2017 Harvey PD, Rosenthal JB. Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging? Schizophrenia Research. PMID 28506706 DOI: 10.1016/J.Schres.2017.05.009  0.571
2017 Harvey PD, Cosentino S, Curiel R, Goldberg TE, Kaye J, Loewenstein D, Marson D, Salmon D, Wesnes K, Posner H. Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum. Innovations in Clinical Neuroscience. 14: 30-39. PMID 28386519  0.734
2017 Posner H, Curiel R, Edgar C, Hendrix S, Liu E, Loewenstein DA, Morrison G, Shinobu L, Wesnes K, Harvey PD. Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs. Innovations in Clinical Neuroscience. 14: 22-29. PMID 28386518  0.724
2017 Czaja SJ, Loewenstein DA, Sabbag SA, Curiel RE, Crocco E, Harvey PD. A Novel Method for Direct Assessment of Everyday Competence Among Older Adults. Journal of Alzheimer's Disease : Jad. PMID 28304300 DOI: 10.3233/Jad-161183  0.805
2017 Ludwig KA, Pinkham AE, Harvey PD, Kelsven S, Penn DL. Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study. Schizophrenia Research. PMID 28302395 DOI: 10.1016/J.Schres.2017.03.001  0.765
2017 Harvey PD, Jacobson W, Zhong W, Nomikos GG, Kurre Olsen C, Merikle E, Cronquist Christensen M. Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder. Journal of Affective Disorders. 213: 105-111. PMID 28213121 DOI: 10.1016/J.Jad.2017.02.014  0.397
2017 Pinkham AE, Kelsven S, Kouros C, Harvey PD, Penn DL. The Effect of Age, Race, and Sex on Social Cognitive Performance in Individuals With Schizophrenia. The Journal of Nervous and Mental Disease. PMID 28141631 DOI: 10.1097/Nmd.0000000000000654  0.751
2017 Blanchard JJ, Bradshaw KR, Garcia CP, Nasrallah HA, Harvey PD, Casey D, Csoboth CT, Hudson JI, Julian L, Lentz E, Nuechterlein KH, Perkins DO, Skale TG, Snowden LR, Tandon R, et al. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study. Schizophrenia Research. PMID 28087270 DOI: 10.1016/J.Schres.2017.01.011  0.815
2017 Moradi H, Olsson A, Hjärthag F, Harvey P, Helldin L. SU42. Physical Fitness in Association With Cognitive Performance—Possible Marker of Short Lifetime Expectancy for Patients With Schizophrenia Schizophrenia Bulletin. 43: S176-S176. DOI: 10.1093/Schbul/Sbx024.040  0.526
2017 Czaja S, Harvey P. SU38. Using Simulations of Everyday Tasks to Train Everyday Task Performance Schizophrenia Bulletin. 43: S174-S175. DOI: 10.1093/Schbul/Sbx024.036  0.468
2017 McClure M, Graff F, Perez-Rodriguez M, Rosell D, Hazlett E, New AS, Harvey P, Siever L. SA25. Guanfacine Augmentation of Cognitive Remediation Therapy in the Schizophrenia Spectrum: Prospects for Improving Cognitive Performance and Functional Skills Schizophrenia Bulletin. 43: S122-S122. DOI: 10.1093/Schbul/Sbx023.024  0.753
2017 Pinkham A, Penn D, Harvey P. M36. Social Cognition Psychometric Evaluation (SCOPE): Results: Of the Final Validation Study Schizophrenia Bulletin. 43: S224-S225. DOI: 10.1093/Schbul/Sbx022.035  0.714
2017 Kemp K, Pinkham A, Shasteen J, Penn D, Harvey P. M33. Recognition of Fearful Faces Depends on Depressive Symptoms in Schizophrenia Schizophrenia Bulletin. 43: S223-S223. DOI: 10.1093/Schbul/Sbx022.032  0.695
2017 Atkins A, Tseng T, Vaughan A, Harvey P, Narasimhan M, Patterson T, Khan A, Keefe R. M25. Development and Validation of the Brief Assessment of Validation in Schizophrenia (BAC-App) Schizophrenia Bulletin. 43: S220-S220. DOI: 10.1093/Schbul/Sbx022.024  0.794
2017 Pinkham A, Hardaway G, Kemp K, Klein H, Harvey P. 61.4 Neural Correlates of Introspective Accuracy in Schizophrenia Schizophrenia Bulletin. 43: S36-S37. DOI: 10.1093/Schbul/Sbx021.096  0.646
2017 Harvey P, Pinkham A, Penn D. 61.1 Introspective Accuracy as a Predictor of Real-World Outcomes Schizophrenia Bulletin. 43: S35-S36. DOI: 10.1093/Schbul/Sbx021.093  0.622
2017 Harvey P. 354. Negative Symptoms and Cognitive Deficits Predict Different Elements of Everyday Functioning in People with Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.371  0.541
2017 Strassnig M, Kotov R, Fochtmann L, Harvey P, Bromet E. 216. 20-Year Progression of BMI in a County-Wide Cohort People with Schizophrenia and Bipolar Disorder Identified at Their First Episode of Psychosis Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.229  0.718
2017 Kalin M, Durand D, Bromet E, Harvey P, Kotov R. 546. A Comparative Study of Accuracy of Self-Assessment in Bipolar and Schizophrenia Patients Focusing on Employment and Living Status Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.1154  0.468
2017 Gould F, Dunlop B, Rosenthal J, Mathew S, Neylan T, Rothbaum B, Nemeroff C, Harvey P. 525. The Temporal Stability of Cognitive Functioning and Functional Capacity in Women with PTSD Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.1133  0.36
2016 Harvey PD, Siu CO, Loebel AD. Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia. Schizophrenia Research. Cognition. 5: 7-12. PMID 28740811 DOI: 10.1016/J.Scog.2016.05.002  0.376
2016 Pinkham AE, Harvey PD, Penn DL. PARANOID INDIVIDUALS WITH SCHIZOPHRENIA SHOW GREATER SOCIAL COGNITIVE BIAS AND WORSE SOCIAL FUNCTIONING THAN NON-PARANOID INDIVIDUALS WITH SCHIZOPHRENIA. Schizophrenia Research. Cognition. 3: 33-38. PMID 27990352 DOI: 10.1016/J.Scog.2015.11.002  0.745
2016 Czaja SJ, Loewenstein DA, Lee CC, Fu SH, Harvey PD. Assessing functional performance using computer-based simulations of everyday activities. Schizophrenia Research. PMID 27913159 DOI: 10.1016/J.Schres.2016.11.014  0.73
2016 Harvey PD. Inflammation in Schizophrenia: What It Means and How to Treat It. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27876351 DOI: 10.1016/J.Jagp.2016.10.012  0.453
2016 Kalman D, Harvey PD, Perez Ojalvo S, Komorowski J. Randomized Prospective Double-Blind Studies to Evaluate the Cognitive Effects of Inositol-Stabilized Arginine Silicate in Healthy Physically Active Adults. Nutrients. 8. PMID 27869715 DOI: 10.3390/Nu8110736  0.321
2016 Wesnes KA, Gommoll C, Chen C, Sambunaris A, McIntyre RS, Harvey PD. Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study. International Clinical Psychopharmacology. PMID 27861191 DOI: 10.1097/Yic.0000000000000157  0.419
2016 Kantrowitz JT, Medalia A, Keefe RS, Harvey PD, Bruder G, Barch DM, Choo T, Lee S, Lieberman JA. Dr Kantrowitz and Colleagues Reply. The Journal of Clinical Psychiatry. 77: e1353. PMID 27788318 DOI: 10.4088/Jcp.16Lr10887A  0.407
2016 Atkins AS, Davis V, Tseng T, Vaughan A, Harvey P, Patterson T, Narasimhan M, Keefe RS. Validation of the tablet-administered Brief Assessment of Cognition (BAC App). Schizophrenia Research. PMID 27771201 DOI: 10.1016/J.Schres.2016.10.010  0.801
2016 Cornacchio D, Pinkham AE, Penn DL, Harvey PD. Self-assessment of social cognitive ability in individuals with schizophrenia: Appraising task difficulty and allocation of effort. Schizophrenia Research. PMID 27693281 DOI: 10.1016/J.Schres.2016.09.033  0.77
2016 Kotwicki RJ, Balzer AM, Harvey PD. Measuring and Facilitating Client Engagement with Financial Incentives: Implications for Improving Clinical Outcomes in a Mental Health Setting. Community Mental Health Journal. PMID 27670284 DOI: 10.1007/S10597-016-0053-Z  0.305
2016 Perna G, Cavedini P, Harvey PD, Di Chiaro NV, Daccò S, Caldirola D. Does neuropsychological performance impact on real-life functional achievements in obsessive-compulsive disorder? A preliminary study. International Journal of Psychiatry in Clinical Practice. 1-8. PMID 27608507 DOI: 10.1080/13651501.2016.1223856  0.324
2016 Harvey PD, Twamley EW, Pinkham AE, Depp CA, Patterson TL. Depression in Schizophrenia: Associations With Cognition, Functional Capacity, Everyday Functioning, and Self-Assessment. Schizophrenia Bulletin. PMID 27440672 DOI: 10.1093/Schbul/Sbw103  0.767
2016 Browne J, Penn DL, Raykov T, Pinkham AE, Kelsven S, Buck B, Harvey PD. Social cognition in schizophrenia: Factor structure of emotion processing and theory of mind. Psychiatry Research. 242: 150-156. PMID 27280525 DOI: 10.1016/J.Psychres.2016.05.034  0.762
2016 Buck BE, Pinkham AE, Harvey PD, Penn DL. Revisiting the validity of measures of social cognitive bias in schizophrenia: Additional results from the Social Cognition Psychometric Evaluation (SCOPE) study. The British Journal of Clinical Psychology / the British Psychological Society. PMID 27168196 DOI: 10.1111/Bjc.12113  0.735
2016 McLaughlin D, Carrión RE, Auther AM, Olvet DM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen RK, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, ... ... Harvey PD, et al. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophrenia Bulletin. PMID 27105902 DOI: 10.1093/Schbul/Sbw039  0.423
2016 Keefe RS, Davis VG, Atkins AS, Vaughan A, Patterson T, Narasimhan M, Harvey PD. Validation of a Computerized test of Functional Capacity. Schizophrenia Research. PMID 27091656 DOI: 10.1016/J.Schres.2016.03.038  0.813
2016 Goldsmith DR, Haroon E, Woolwine BJ, Jung MY, Wommack EC, Harvey PD, Treadway MT, Felger JC, Miller AH. Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain, Behavior, and Immunity. PMID 27040122 DOI: 10.1016/J.Bbi.2016.03.025  0.317
2016 Kantrowitz JT, Sharif Z, Medalia A, Keefe RS, Harvey P, Bruder G, Barch DM, Choo T, Lee S, Lieberman JA. A multicenter, rater-blinded, randomized controlled study of auditory processing-focused cognitive remediation combined with open-label lurasidone in patients with schizophrenia and schizoaffective disorder. The Journal of Clinical Psychiatry. PMID 27035157 DOI: 10.4088/Jcp.15M09998  0.636
2016 Harvey PD, Rosenthal JB. Treatment resistant schizophrenia: Course of brain structure and function. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 26925705 DOI: 10.1016/J.Pnpbp.2016.02.008  0.452
2016 Burton CZ, Harvey PD, Patterson TL, Twamley EW. Neurocognitive insight and objective cognitive functioning in schizophrenia. Schizophrenia Research. 171: 131-6. PMID 26811232 DOI: 10.1016/J.Schres.2016.01.021  0.715
2016 Harvey PD, Aslan M, Du M, Zhao H, Siever LJ, Pulver A, Gaziano JM, Concato J. Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies. Neuropsychology. 30: 28-39. PMID 26710094 DOI: 10.1037/Neu0000245  0.547
2016 Harvey PD, Ogasa M, Siu C, Loebel A. Lurasidone Effects on Cognition and Functional Capacity in Schizophrenia Clinical Neuropsychopharmacology and Therapeutics. 7: 11-19. DOI: 10.5234/CNPT.7.11  0.468
2016 Jacobson W, Harvey PD, Merikle E, Zhong W, Nomikos G, Olsen CK, Christensen MC. PS83. Impact of Vortioxetine on Functional Capacity in MDD Patients with Subjective Cognitive Dysfunction: A Post-hoc Analysis of the University of California San Diego Performance-Based Skills Assessment The International Journal of Neuropsychopharmacology. 19: 28-28. DOI: 10.1093/Ijnp/Pyw043.083  0.445
2016 Burton CZ, Harvey PD, Patterson TL, Twamley EW. Neurocognitive insight and objective cognitive functioning in schizophrenia Schizophrenia Research. 171: 131-136. DOI: 10.1016/j.schres.2016.01.021  0.68
2016 Berkowsky RW, Czaja SJ, Harvey PD. Designing a web-based application to train aging adults to successfully use technologies important to independent living Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 9755: 289-299. DOI: 10.1007/978-3-319-39949-2_28  0.422
2015 Sumiyoshi C, Harvey PD, Takaki M, Okahisa Y, Sato T, Sora I, Nuechterlein KH, Subotnik KL, Sumiyoshi T. Factors predicting work outcome in Japanese patients with schizophrenia: role of multiple functioning levels. Schizophrenia Research. Cognition. 2: 105-112. PMID 29379760 DOI: 10.1016/J.Scog.2015.07.003  0.506
2015 Goldberg TE, Harvey PD, Wesnes KA, Snyder PJ, Schneider LS. Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 103-11. PMID 27239497 DOI: 10.1016/J.Dadm.2014.11.003  0.377
2015 Siu CO, Harvey PD, Agid O, Waye M, Brambilla C, Choi WK, Remington G. Insight and subjective measures of quality of life in chronic schizophrenia. Schizophrenia Research. Cognition. 2: 127-132. PMID 26973810 DOI: 10.1016/J.Scog.2015.05.002  0.456
2015 Atkins AS, Stroescu I, Spagnola NB, Davis VG, Patterson TD, Narasimhan M, Harvey PD, Keefe RS. Assessment of Age-Related Differences in Functional Capacity Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT). The Journal of Prevention of Alzheimer's Disease. 2: 121-127. PMID 26618145 DOI: 10.14283/jpad.2015.61  0.707
2015 Golier JA, Caramanica K, Michaelides AC, Makotkine I, Schmeidler J, Harvey PD, Yehuda R. A randomized, double-blind, placebo-controlled, crossover trial of mifepristone in Gulf War veterans with chronic multisymptom illness. Psychoneuroendocrinology. 64: 22-30. PMID 26600007 DOI: 10.3402/Ejpt.V3I0.19474  0.356
2015 Keefe RS, Harvey PD. Understanding Symbol Coding in Schizophrenia. Biological Psychiatry. 78: 744-6. PMID 26542742 DOI: 10.1016/J.Biopsych.2015.09.005  0.638
2015 Moore RC, Harmell AL, Harvey PD, Bowie CR, Depp CA, Pulver AE, McGrath JA, Patterson TL, Cardenas V, Wolyniec P, Thornquist MH, Luke JR, Palmer BW, Jeste DV, Mausbach BT. Improving the understanding of the link between cognition and functional capacity in schizophrenia and bipolar disorder. Schizophrenia Research. PMID 26427917 DOI: 10.1016/J.Schres.2015.09.017  0.838
2015 Helldin L, Hjärthag F, Olsson AK, Harvey PD. Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study. Schizophrenia Research. PMID 26391285 DOI: 10.1016/J.Schres.2015.09.009  0.531
2015 Keefe RS, Haig GM, Marder SR, Harvey PD, Dunayevich E, Medalia A, Davidson M, Lombardo I, Bowie CR, Buchanan RW, Bugarski-Kirola D, Carpenter WT, Csernansky JT, Dago PL, Durand DM, et al. Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia. Schizophrenia Bulletin. PMID 26362273 DOI: 10.1093/Schbul/Sbv111  0.793
2015 Spagna A, Dong Y, Mackie MA, Li M, Harvey PD, Tian Y, Wang K, Fan J. Clozapine improves the orienting of attention in schizophrenia. Schizophrenia Research. PMID 26298539 DOI: 10.1016/J.Schres.2015.08.009  0.502
2015 Kalin M, Kaplan S, Gould F, Pinkham AE, Penn DL, Harvey PD. Social cognition, social competence, negative symptoms and social outcomes: Inter-relationships in people with schizophrenia. Journal of Psychiatric Research. 68: 254-60. PMID 26228427 DOI: 10.1016/J.Jpsychires.2015.07.008  0.716
2015 Strassnig MT, Signorile JF, Potiaumpai M, Romero MA, Gonzalez C, Czaja S, Harvey PD. High velocity circuit resistance training improves cognition, psychiatric symptoms and neuromuscular performance in overweight outpatients with severe mental illness. Psychiatry Research. 229: 295-301. PMID 26187340 DOI: 10.1016/J.Psychres.2015.07.007  0.783
2015 Sabbag S, Prestia D, Robertson B, Ruiz P, Durand D, Strassnig M, Harvey PD. Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophrenia. Psychiatry Research. 229: 347-52. PMID 26160197 DOI: 10.1016/J.Psychres.2015.06.042  0.728
2015 Harvey PD, Siu CO, Ogasa M, Loebel A. Effect of lurasidone dose on cognition in patients with schizophrenia: post-hoc analysis of a long-term, double-blind continuation study. Schizophrenia Research. 166: 334-8. PMID 26117157 DOI: 10.1016/J.Schres.2015.06.008  0.33
2015 Harvey PD, Paschall G, Depp C. Factors influencing self-assessment of cognition and functioning in bipolar disorder: a preliminary study. Cognitive Neuropsychiatry. 20: 361-71. PMID 26057868 DOI: 10.1080/13546805.2015.1044510  0.693
2015 Glick HA, Li P, Harvey PD. The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: An analysis of the CATIE Schizophrenia Trial. Schizophrenia Research. 166: 110-4. PMID 26044113 DOI: 10.1016/J.Schres.2015.05.021  0.432
2015 Nasrallah HA, Harvey PD, Casey D, Csoboth CT, Hudson JI, Julian L, Lentz E, Nuechterlein KH, Perkins DO, Kotowsky N, Skale TG, Snowden LR, Tandon R, Tek C, Velligan D, et al. The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: A focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization. Schizophrenia Research. PMID 26027848 DOI: 10.1016/J.Schres.2015.04.031  0.474
2015 Harvey PD. The clinical utility of lurasidone in schizophrenia: patient considerations. Neuropsychiatric Disease and Treatment. 11: 1103-9. PMID 25995636 DOI: 10.2147/Ndt.S68417  0.469
2015 Harvey PD, Keefe RS. Methods for delivering and evaluating the efficacy of cognitive enhancement. Handbook of Experimental Pharmacology. 228: 5-25. PMID 25977078 DOI: 10.1007/978-3-319-16522-6_1  0.61
2015 Pinkham AE, Penn DL, Green MF, Harvey PD. Social Cognition Psychometric Evaluation: Results of the Initial Psychometric Study. Schizophrenia Bulletin. PMID 25943125 DOI: 10.1093/Schbul/Sbv056  0.687
2015 Strassnig MT, Raykov T, O'Gorman C, Bowie CR, Sabbag S, Durand D, Patterson TL, Pinkham A, Penn DL, Harvey PD. Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity. Schizophrenia Research. 165: 76-82. PMID 25868935 DOI: 10.1016/J.Schres.2015.03.033  0.86
2015 Shah SS, Dellarole A, Peterson EC, Bregy A, Komotar R, Harvey PD, Elhammady MS. Long-term psychiatric outcomes in pediatric brain tumor survivors. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 31: 653-63. PMID 25726165 DOI: 10.1007/S00381-015-2669-7  0.541
2015 Gould F, McGuire LS, Durand D, Sabbag S, Larrauri C, Patterson TL, Twamley EW, Harvey PD. Self-Assessment in Schizophrenia: Accuracy of Evaluation of Cognition and Everyday Functioning. Neuropsychology. PMID 25643212 DOI: 10.1037/Neu0000175  0.736
2015 Depp CA, Bowie CR, Mausbach BT, Wolyniec P, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Patterson TL, Harvey PD. Current smoking is associated with worse cognitive and adaptive functioning in serious mental illness. Acta Psychiatrica Scandinavica. 131: 333-41. PMID 25559296 DOI: 10.1111/Acps.12380  0.756
2015 Durand D, Strassnig M, Sabbag S, Gould F, Twamley EW, Patterson TL, Harvey PD. Factors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 185-91. PMID 25104226 DOI: 10.1016/J.Euroneuro.2014.07.008  0.818
2015 Rosell DR, Zaluda LC, McClure MM, Perez-Rodriguez MM, Strike KS, Barch DM, Harvey PD, Girgis RR, Hazlett EA, Mailman RB, Abi-Dargham A, Lieberman JA, Siever LJ. Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 446-53. PMID 25074637 DOI: 10.1038/Npp.2014.192  0.688
2015 Keefe RS, Davis VG, Spagnola NB, Hilt D, Dgetluck N, Ruse S, Patterson TD, Narasimhan M, Harvey PD. Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 176-84. PMID 25028065 DOI: 10.1016/J.Euroneuro.2014.06.009  0.725
2015 Potiaumpai M, Romero MA, Signorile JF, Harvey PD, Gonzalez CM, Strassnig M. Measures Of Physical Function In Patients With Persistent Mental Illness After High-velocity Circuit Resistance-training Medicine & Science in Sports & Exercise. 47: 678. DOI: 10.1249/01.Mss.0000478571.20691.7A  0.632
2015 Romero MA, Potiaumpai M, Signorile JF, Harvey PD, Gonzalez CM, Strassnig M. The Effects of an 8-Week High Velocity Resistance Circuit Training Program in Patients with Schizophrenia Medicine & Science in Sports & Exercise. 47: 667. DOI: 10.1249/01.Mss.0000478541.74056.6D  0.676
2015 Harvey PD, Siu CO, Ogasa M, Loebel A. Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double-blind continuation study Schizophrenia Research. DOI: 10.1016/j.schres.2015.06.008  0.375
2015 Sabbag S, Prestia D, Robertson B, Ruiz P, Durand D, Strassnig M, Harvey PD. Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophrenia Psychiatry Research. DOI: 10.1016/j.psychres.2015.06.042  0.335
2015 Kalin M, Kaplan S, Gould F, Pinkham AE, Penn DL, Harvey PD. Social cognition, social competence, negative symptoms and social outcomes: Inter-relationships in people with schizophrenia Journal of Psychiatric Research. 68: 254-260. DOI: 10.1016/j.jpsychires.2015.07.008  0.709
2015 Gould F, Kaplan S, Harvey PD. Latest Developments in Cognitive Functioning in Mood and Anxiety Disorders Current Behavioral Neuroscience Reports. 2: 165-172. DOI: 10.1007/S40473-015-0045-2  0.436
2014 Sumiyoshi C, Takaki M, Okahisa Y, Patterson TL, Harvey PD, Sumiyoshi T. Utility of the UCSD Performance-based Skills Assessment-Brief Japanese version: discriminative ability and relation to neurocognition. Schizophrenia Research. Cognition. 1: 137-143. PMID 29379746 DOI: 10.1016/J.Scog.2014.08.002  0.682
2014 Robertson BR, Prestia D, Twamley EW, Patterson TL, Bowie CR, Harvey PD. Social competence versus negative symptoms as predictors of real world social functioning in schizophrenia. Schizophrenia Research. 160: 136-41. PMID 25468184 DOI: 10.1016/S0924-9338(15)31351-1  0.728
2014 Strassnig MT, Harvey PD. Treatment resistance and other complicating factors in the management of schizophrenia. Cns Spectrums. 19: 16-23; quiz 13-5, 24. PMID 25410772 DOI: 10.1017/S1092852914000571  0.692
2014 Harvey PD. Assessing disability in schizophrenia: tools and contributors. The Journal of Clinical Psychiatry. 75: e27. PMID 25373132 DOI: 10.4088/Jcp.13049Tx5C  0.546
2014 Best MW, Gupta M, Bowie CR, Harvey PD. A Longitudinal Examination of the Moderating Effects of Symptoms on the Relationship between Functional Competence and Real World Functional Performance in Schizophrenia. Schizophrenia Research. Cognition. 1: 90-95. PMID 25267939 DOI: 10.1016/J.Scog.2014.03.002  0.688
2014 Strassnig M, Signorile J, Gonzalez C, Harvey PD. Physical performance and disability in schizophrenia. Schizophrenia Research. Cognition. 1: 112-121. PMID 25254158 DOI: 10.1016/J.Scog.2014.06.002  0.744
2014 Vargas G, Strassnig M, Sabbag S, Gould F, Durand D, Stone L, Patterson TL, Harvey PD. The course of vocational functioning in patients with schizophrenia: Re-examining social drift. Schizophrenia Research. Cognition. 1: e41-e46. PMID 25254157 DOI: 10.1016/J.Scog.2014.01.001  0.811
2014 Green MF, Harvey PD. Cognition in schizophrenia: Past, present, and future. Schizophrenia Research. Cognition. 1: e1-e9. PMID 25254156 DOI: 10.1016/J.Scog.2014.02.001  0.55
2014 Ruse SA, Harvey PD, Davis VG, Atkins AS, Fox KH, Keefe RS. Virtual Reality Functional Capacity Assessment In Schizophrenia: Preliminary Data Regarding Feasibility and Correlations with Cognitive and Functional Capacity Performance. Schizophrenia Research. Cognition. 1: e21-e26. PMID 25083416 DOI: 10.1016/J.Scog.2014.01.004  0.792
2014 Reichenberg A, Feo C, Prestia D, Bowie CR, Patterson TL, Harvey PD. The Course and Correlates of Everyday Functioning in Schizophrenia. Schizophrenia Research. Cognition. 1: e47-e52. PMID 25045625 DOI: 10.1016/J.Scog.2014.03.001  0.777
2014 Keefe RS, Fox KH, Davis VG, Kennel C, Walker TM, Burdick KE, Harvey PD. The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls. Journal of Affective Disorders. 166: 86-92. PMID 25012414 DOI: 10.1016/J.Jad.2014.05.002  0.614
2014 Garcia-Portilla MP, Gomar J, Bobes-Bascaran MT, Menendez-Miranda I, Saiz PA, Muñiz J, Arango C, Patterson T, Harvey P, Bobes J, Goldberg T. [Development of the Spanish brief-version of the University of California Performance Skills Assessment (Sp-UPSA-Brief) in patients with schizophrenia and bipolar disorder]. Revista De Psiquiatrí́a Y Salud Mental. 7: 113-20. PMID 24984573 DOI: 10.1016/J.Rpsmen.2014.06.006  0.68
2014 Kaye JL, Dunlop BW, Iosifescu DV, Mathew SJ, Kelley ME, Harvey PD. Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: examining the convergence of performance-based measures and self-reports. Journal of Psychiatric Research. 57: 51-7. PMID 24974001 DOI: 10.1016/J.Jpsychires.2014.06.002  0.431
2014 Harvey PD. What is the evidence for changes in cognition and functioning over the lifespan in patients with schizophrenia? The Journal of Clinical Psychiatry. 75: 34-8. PMID 24919170 DOI: 10.4088/Jcp.13065Su1.08  0.511
2014 Harvey PD, Siever LJ, Huang GD, Muralidhar S, Zhao H, Miller P, Aslan M, Mane S, McNamara M, Gleason T, Brophy M, Przygodszki R, O'Leary TJ, Gaziano M, Concato J. The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 165: 381-9. PMID 24798943 DOI: 10.1002/Ajmg.B.32242  0.52
2014 Ruse SA, Davis VG, Atkins AS, Krishnan KR, Fox KH, Harvey PD, Keefe RS. Development of a virtual reality assessment of everyday living skills. Journal of Visualized Experiments : Jove. PMID 24798174 DOI: 10.3791/51405  0.791
2014 Harvey PD. A cognitive neuroscience trifecta. The American Journal of Psychiatry. 171: 482-4. PMID 24788277 DOI: 10.1176/Appi.Ajp.2014.14010111  0.398
2014 Depp CA, Strassnig M, Mausbach BT, Bowie CR, Wolyniec P, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Patterson TL, Harvey PD. Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia. Bipolar Disorders. 16: 422-31. PMID 24725166 DOI: 10.1111/Bdi.12200  0.825
2014 Rakofsky JJ, Dunlop BW, Beyer JL, Oliver AM, Mansson EE, Sancheti MT, Harvey PD. Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder. Journal of Clinical Psychopharmacology. 34: 383-5. PMID 24717252 DOI: 10.1097/Jcp.0000000000000078  0.419
2014 Pogge DL, Stokes J, Buccolo ML, Pappalardo S, Harvey PD. Discovery of previously undetected intellectual disability by psychological assessment: a study of consecutively referred child and adolescent psychiatric inpatients. Research in Developmental Disabilities. 35: 1705-10. PMID 24679700 DOI: 10.1016/J.Ridd.2014.03.012  0.324
2014 Cáceda R, Nemeroff CB, Harvey PD. Toward an understanding of decision making in severe mental illness. The Journal of Neuropsychiatry and Clinical Neurosciences. 26: 196-213. PMID 24599051 DOI: 10.1176/Appi.Neuropsych.12110268  0.411
2014 Harvey PD. Disability in schizophrenia: contributing factors and validated assessments. The Journal of Clinical Psychiatry. 75: 15-20. PMID 24581454 DOI: 10.4088/Jcp.13049Su1C.03  0.536
2014 Loebel AD, Siu CO, Cucchiaro JB, Pikalov AA, Harvey PD. Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia. Cns Spectrums. 19: 197-205. PMID 24330860 DOI: 10.1017/S1092852913000904  0.389
2014 Holshausen K, Bowie CR, Mausbach BT, Patterson TL, Harvey PD. Neurocognition, functional capacity, and functional outcomes: the cost of inexperience. Schizophrenia Research. 152: 430-4. PMID 23978775 DOI: 10.1016/J.Schres.2013.08.004  0.735
2014 Pinkham AE, Penn DL, Green MF, Buck B, Healey K, Harvey PD. The social cognition psychometric evaluation study: results of the expert survey and RAND panel. Schizophrenia Bulletin. 40: 813-23. PMID 23728248 DOI: 10.1093/Schbul/Sbt081  0.733
2014 Holshausen K, Harvey PD, ElvevÃ¥g B, Foltz PW, Bowie CR. Latent semantic variables are associated with formal thought disorder and adaptive behavior in older inpatients with schizophrenia. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 55: 88-96. PMID 23510635 DOI: 10.1016/J.Cortex.2013.02.006  0.626
2014 Bowie CR, Grossman M, Gupta M, Oyewumi LK, Harvey PD. Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness. Early Intervention in Psychiatry. 8: 32-8. PMID 23343011 DOI: 10.1111/Eip.12029  0.682
2014 Kane JM, Correll CU, Harvey PD, Olfson M. Clinical and Cost Implications of Treating Schizophrenia The Journal of Clinical Psychiatry. 75: e20. DOI: 10.4088/Jcp.13050Ip1  0.412
2014 Harvey PD. When Treatment of Schizophrenia Fails, What Happens Next? Psyccritiques. 59. DOI: 10.1037/a0038049  0.34
2014 Loebel A, Siu C, Cucchiaro J, Pikalov A, Harvey P. P.3.d.065 Evaluation of daytime sleepiness in patients with schizophrenia treated with atypical antipsychotics European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70898-3  0.425
2014 Siu C, Agid O, Waye M, Brambilla C, Remington G, Harvey P. P.3.d.038 Insight into illness and uncooperativeness in chronic schizophrenia European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70871-5  0.397
2014 Harvey P, Siu C, Cucchiaro J, Pikalov A, Loebel A. EPA-0321 – Impact of improved insight in schizophrenia: a double-blind lurasidone and quetiapine xr study European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)77757-0  0.493
2014 Harvey PD, O'Gorman C. Poster #M251 METHODOLOGICAL CONSIDERATIONS IN THE IMPLEMENTATION OF THE US MOSAIC REGISTRY: A LARGE-SCALE LONG TERM STUDY OF PEOPLE WITH SCHIZOPHRENIA Schizophrenia Research. 153: S281. DOI: 10.1016/S0920-9964(14)70801-1  0.39
2014 Pikalov A, Harvey PD, Siu C, Cucchiaro J, Loebel A. Poster #M238 EFFECT OF LURASIDONE ON COGNITIVE IMPAIRMENT: FROM THE LAB TO THE CLINIC Schizophrenia Research. 153: S276. DOI: 10.1016/S0920-9964(14)70788-1  0.383
2014 Sumiyoshi C, Takaki M, Okahisa Y, Patterson T, Harvey PD, Sumiyoshi T. Poster #M210 THE UCSD PERFORMANCE-BASED SKILLS ASSESSMENT-BRIEF JAPANESE VERSION (UPSA-B_J): DISCRIMINATIVE VALIDITY FOR SCHIZOPHRENIA Schizophrenia Research. 153: S266. DOI: 10.1016/S0920-9964(14)70760-1  0.641
2014 O'Gorman C, Harvey PD. Poster #M165 NEGATIVE SYMPTOMS OF SCHIZOPHRENIA CORRELATE SPECIFICALLY WITH DEFICITS IN SOCIAL FUNCTIONING Schizophrenia Research. 153: S250. DOI: 10.1016/S0920-9964(14)70715-7  0.479
2014 Agid O, Siu C, Harvey PD, Zipursky R, Fervaha G, Foussias G, McDonald K, Remington G. Poster #S211 TREATMENT OUTCOMES, INSIGHT AND RECOVERY IN FIRST-EPISODE SCHIZOPHRENIA Schizophrenia Research. 153: S165-S166. DOI: 10.1016/S0920-9964(14)70490-6  0.429
2014 Harvey PD, Loebel A, Cucchiaro J, Phillips D, Siu C. Poster #S166 IS QUALITY OF LIFE RELATED TO COGNITIVE PERFORMANCE OR NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA? RESULTS FROM A DOUBLE-BLIND, ACTIVE-CONTROLLED, LURASIDONE CONTINUATION STUDY Schizophrenia Research. 153: S149. DOI: 10.1016/S0920-9964(14)70445-1  0.492
2014 Siu C, Agid O, Waye M, Brambilla C, Choi W, Remington G, Harvey PD. Poster #S102 INSIGHT INTO ILLNESS, COGNITIVE REASONING AND UNCOOPERATIVENESS IN CHRONIC SCHIZOPHRENIA Schizophrenia Research. 153: S125-S126. DOI: 10.1016/S0920-9964(14)70381-0  0.511
2014 Siever LJ, Rosell D, McClure M, Strike K, Barch DM, Harvey P, Girgis R, Lieberman J, Giakoumaki S, Bitsios P, Roussos P, Haroutunian V. THE D1 RECEPTOR AND COGNITION AND TRIAL OF A NOVEL D1 AGONIST IN THE SCHIZOPHRENIA SPECTRUM Schizophrenia Research. 153: S5-S6. DOI: 10.1016/S0920-9964(14)70017-9  0.699
2014 Sumiyoshi C, Harvey PD, Takaki M, Okahisa Y, Sato T, Sora I, Nuechterlein KH, Subotnik KL, Sumiyoshi T. Factors predicting work outcome in Japanese patients with schizophrenia: Role of multiple functioning levels Schizophrenia Research: Cognition. DOI: 10.1016/j.scog.2015.07.003  0.329
2014 Khan A, Lindenmayer JP, Opler M, Kelley ME, White L, Compton M, Gao Z, Harvey PD. The evolution of illness phases in schizophrenia: A non-parametric item response analysis of the Positive and Negative Syndrome Scale Schizophrenia Research: Cognition. 1: 53-89. DOI: 10.1016/J.Scog.2014.01.002  0.386
2014 Garcia-Portilla MP, Gomar JJ, Bobes-Bascaran MT, Menendez-Miranda I, Saiz PA, Muñiz J, Arango C, Patterson T, Harvey P, Bobes J, Goldberg T. Development of the Spanish Brief-version of the University of California Performance Skills Assessment (Sp-UPSA-Brief) in patients with schizophrenia and bipolar disorder Revista De Psiquiatría Y Salud Mental (English Edition). 7: 113-120. DOI: 10.1016/J.RPSMEN.2014.06.006  0.627
2014 Kasckow J, Harvey PD, Cohen CI, Rajii T. Cognition and Functioning in Older Patients With Schizophrenia: Recent Research The American Journal of Geriatric Psychiatry. 22: S8. DOI: 10.1016/J.Jagp.2013.12.012  0.529
2013 Harvey PD. Cognitive aspects of schizophrenia. Wiley Interdisciplinary Reviews. Cognitive Science. 4: 599-608. PMID 26304266 DOI: 10.1002/Wcs.1253  0.513
2013 Strassnig M, Harvey PD. Treatment of obesity and disability in schizophrenia. Innovations in Clinical Neuroscience. 10: 15-9. PMID 24062969  0.714
2013 Garcia-Portilla MP, Gomar JJ, Bobes-Bascaran MT, Menendez-Miranda I, Saiz PA, Muñiz J, Arango C, Patterson TL, Harvey PD, Bobes J, Goldberg TE. Validation of a European Spanish-version of the University of California performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorder. Schizophrenia Research. 150: 421-6. PMID 24055246 DOI: 10.1016/J.Schres.2013.07.049  0.644
2013 Harvey PD, Siu CO, Hsu J, Cucchiaro J, Maruff P, Loebel A. Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1373-82. PMID 24035633 DOI: 10.1016/J.Euroneuro.2013.08.003  0.448
2013 Marder SR, Alphs L, Anghelescu IG, Arango C, Barnes TR, Caers I, Daniel DG, Dunayevich E, Fleischhacker WW, Garibaldi G, Green MF, Harvey PD, Kahn RS, Kane JM, Keefe RS, et al. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophrenia Research. 150: 328-33. PMID 24028744 DOI: 10.1016/J.Schres.2013.07.058  0.546
2013 McGurk SR, Mueser KT, Mischel R, Adams R, Harvey PD, McClure MM, Look AE, Leung WW, Siever LJ. Vocational functioning in schizotypal and paranoid personality disorders. Psychiatry Research. 210: 498-504. PMID 23932840 DOI: 10.1016/J.Psychres.2013.06.019  0.832
2013 Harvey PD. Commentary on "Cognition in schizophrenia". European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 781-3. PMID 23669060 DOI: 10.1016/J.Euroneuro.2013.04.006  0.541
2013 Harvey PD. Assessment of everyday functioning in schizophrenia: implications for treatments aimed at negative symptoms. Schizophrenia Research. 150: 353-5. PMID 23668973 DOI: 10.1016/J.Schres.2013.04.022  0.502
2013 Gould F, Sabbag S, Durand D, Patterson TL, Harvey PD. Self-assessment of functional ability in schizophrenia: milestone achievement and its relationship to accuracy of self-evaluation. Psychiatry Research. 207: 19-24. PMID 23537844 DOI: 10.1016/J.Psychres.2013.02.035  0.708
2013 Harvey PD, Stone L, Lowenstein D, Czaja SJ, Heaton RK, Twamley EW, Patterson TL. The convergence between self-reports and observer ratings of financial skills and direct assessment of financial capabilities in patients with schizophrenia: more detail is not always better. Schizophrenia Research. 147: 86-90. PMID 23537475 DOI: 10.1016/J.Schres.2013.02.018  0.768
2013 Burton CZ, Vella L, Harvey PD, Patterson TL, Heaton RK, Twamley EW. Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia. Schizophrenia Research. 146: 244-8. PMID 23507359 DOI: 10.1016/J.Schres.2013.02.026  0.755
2013 Harvey PD, Raykov T, Twamley EW, Vella L, Heaton RK, Patterson TL. Factor structure of neurocognition and functional capacity in schizophrenia: a multidimensional examination of temporal stability. Journal of the International Neuropsychological Society : Jins. 19: 656-63. PMID 23425725 DOI: 10.1017/S1355617713000179  0.714
2013 McClure MM, Harvey PD, Bowie CR, Iacoviello B, Siever LJ. Functional outcomes, functional capacity, and cognitive impairment in schizotypal personality disorder. Schizophrenia Research. 144: 146-50. PMID 23375943 DOI: 10.1016/J.Schres.2012.12.012  0.816
2013 Pinkham AE, Harvey PD. Future directions for social cognitive interventions in schizophrenia. Schizophrenia Bulletin. 39: 499-500. PMID 23223247 DOI: 10.1093/Schbul/Sbs142  0.679
2013 Harvey PD, Loewenstein DA, Czaja SJ. Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia. Neurobiology of Disease. 53: 18-25. PMID 23123218 DOI: 10.1016/J.Nbd.2012.10.022  0.757
2013 Reinares M, Papachristou E, Harvey P, Mar Bonnín C, Sánchez-Moreno J, Torrent C, Ayuso-Mateos JL, Ploubidis GB, Vieta E, Frangou S. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. Journal of Affective Disorders. 144: 65-71. PMID 22862890 DOI: 10.1016/J.Jad.2012.06.005  0.366
2013 Agid O, Siu C, Harvey P, Zipursky R, Remington G. P.3.b.034 Insight, treatment outcomes and recovery in first-episode schizophrenia European Neuropsychopharmacology. 23: S449. DOI: 10.1016/S0924-977X(13)70711-9  0.409
2013 Siu C, Agid O, Waye M, Brambilla C, Remington G, Harvey P. P.1.j.027 Insight into illness and subjective quality-of-life assessment in chronic schizophrenia European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70465-6  0.384
2013 Harvey P, Siu CO, Cucchiaro J, Pikalov A, Loebel A. P.1.j.007 Impact of improved insight in schizophrenia: a double-blind lurasidone and quetiapine XR study European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70445-0  0.437
2012 Harvey PD, Sabbag S, Prestia D, Durand D, Twamley EW, Patterson TL. Functional milestones and clinician ratings of everyday functioning in people with schizophrenia: overlap between milestones and specificity of ratings. Journal of Psychiatric Research. 46: 1546-52. PMID 22979993 DOI: 10.1016/J.Jpsychires.2012.08.018  0.634
2012 Harvey PD, Bowie CR. Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches. The Psychiatric Clinics of North America. 35: 683-98. PMID 22929873 DOI: 10.1016/J.Psc.2012.06.008  0.705
2012 Harvey PD, Bowie CR. Cognitive remediation in severe mental illness. Innovations in Clinical Neuroscience. 9: 27-30. PMID 22666639  0.576
2012 Harvey PD, Strassnig M. Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 11: 73-9. PMID 22654932 DOI: 10.1016/J.Wpsyc.2012.05.004  0.755
2012 Harvey PD. Cognitive impairment in schizophrenia: profile, course, and neurobiological determinants. Handbook of Clinical Neurology. 106: 433-45. PMID 22608636 DOI: 10.1016/B978-0-444-52002-9.00025-5  0.547
2012 Bowie CR, McGurk SR, Mausbach B, Patterson TL, Harvey PD. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. The American Journal of Psychiatry. 169: 710-8. PMID 22581070 DOI: 10.1176/Appi.Ajp.2012.11091337  0.768
2012 Depp CA, Mausbach BT, Harmell AL, Savla GN, Bowie CR, Harvey PD, Patterson TL. Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disorders. 14: 217-26. PMID 22548895 DOI: 10.1111/J.1399-5618.2012.01011.X  0.807
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophrenia Research. 140: 1-8. PMID 22503642 DOI: 10.1016/J.Schres.2012.03.025  0.635
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophrenia Research. 140: 9-14. PMID 22503641 DOI: 10.1016/J.Schres.2012.03.026  0.59
2012 Sabbag S, Twamley EW, Vella L, Heaton RK, Patterson TL, Harvey PD. Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia. Schizophrenia Research. 137: 190-5. PMID 22386735 DOI: 10.1016/J.Schres.2012.02.002  0.711
2012 Gould F, Clarke J, Heim C, Harvey PD, Majer M, Nemeroff CB. The effects of child abuse and neglect on cognitive functioning in adulthood. Journal of Psychiatric Research. 46: 500-6. PMID 22336639 DOI: 10.1016/J.Jpsychires.2012.01.005  0.459
2012 Gould F, Bowie CR, Harvey PD. The influence of demographic factors on functional capacity and everyday functional outcomes in schizophrenia. Journal of Clinical and Experimental Neuropsychology. 34: 467-75. PMID 22272559 DOI: 10.1080/13803395.2011.651102  0.658
2012 Loewenstein DA, Czaja SJ, Bowie CR, Harvey PD. Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 29-40. PMID 22130385 DOI: 10.1097/Jgp.0B013E31823Bc08C  0.796
2012 Depp CA, Mausbach BT, Bowie C, Wolyniec P, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Harvey PD, Patterson TL. Determinants of occupational and residential functioning in bipolar disorder. Journal of Affective Disorders. 136: 812-8. PMID 22129770 DOI: 10.1016/J.Jad.2011.09.035  0.788
2012 Harvey PD, Czaja SJ, Loewenstein DA. Schizophrenia in later life. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 1-4. PMID 22104378 DOI: 10.1097/Jgp.0B013E31823Bbf93  0.733
2012 Harvey PD, McClure MM, Patterson TL, McGrath JA, Pulver AE, Bowie CR, Siever LJ. Impairment in functional capacity as an endophenotype candidate in severe mental illness. Schizophrenia Bulletin. 38: 1318-26. PMID 21562142 DOI: 10.1093/Schbul/Sbr046  0.826
2012 Strassnig MT, Caceda R, Newcomer JW, Harvey PD. Cognitive deficits, obesity and disability in schizophrenia Translational Neuroscience. 3: 345-354. DOI: 10.2478/S13380-012-0046-5  0.743
2012 Feo C, Prestía D, Bowie CR, Harvey PD. Poster #229 LONGITUDINAL CHANGES IN EVERYDAY FUNCTIONING IN OLDER PATIENTS WITH SCHIZOPHRENIA: THE ROLE OF CHANGES IN FUNCTIONAL CAPACITY Schizophrenia Research. 136: S268. DOI: 10.1016/S0920-9964(12)70800-9  0.64
2012 Czaja SJ, Loewenstein DA, Sherin JE, Harvey PD. Poster #258 VARIATION IN FUNCTIONAL RATINGS OF PATIENTS WITH SCHIZOPHRENIA AMONG DIFFERENT TYPES OF INFORMANTS AND THE RELATIONSHIP TO OBJECTIVE MEASURES OF ABILITY Schizophrenia Research. 136: S183. DOI: 10.1016/S0920-9964(12)70570-4  0.708
2012 Prestia D, Sabbag S, Harvey PD. Poster #194 FUNCTIONAL STATUS RATING SCALES AS PREDICTORS OF EVERYDAY FUNCTIONING IN PEOPLE WITH SCHIZOPHRENIA: GLOBAL VS SUBSCALES RATINGS Schizophrenia Research. 136: S160-S161. DOI: 10.1016/S0920-9964(12)70508-X  0.443
2012 Harvey PD, Ruse S, Davis V, Solomon M, Keefe R. 14:30 COMPUTERIZED FUNCTIONAL CAPACITY ASSESSMENTIN SCHIZOPHRENIA: EVIDENCE FOR CONVERGENT VALIDITY Schizophrenia Research. 136: S78-S79. DOI: 10.1016/S0920-9964(12)70284-0  0.635
2011 Gomar JJ, Harvey PD, Bobes-Bascaran MT, Davies P, Goldberg TE. Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 915-22. PMID 22024615 DOI: 10.1097/JGP.0b013e3182011846  0.33
2011 Mausbach BT, Depp CA, Bowie CR, Harvey PD, McGrath JA, Thronquist MH, Luke JR, Wolyniec PS, Pulver AE, Patterson TL. Sensitivity and specificity of the UCSD Performance-based Skills Assessment (UPSA-B) for identifying functional milestones in schizophrenia. Schizophrenia Research. 132: 165-70. PMID 21843926 DOI: 10.1016/J.Schres.2011.07.022  0.777
2011 Sabbag S, Twamley EM, Vella L, Heaton RK, Patterson TL, Harvey PD. Assessing everyday functioning in schizophrenia: not all informants seem equally informative. Schizophrenia Research. 131: 250-5. PMID 21620682 DOI: 10.1016/J.Schres.2011.05.003  0.705
2011 Cubells JF, Deoreo EH, Harvey PD, Garlow SJ, Garber K, Adam MP, Martin CL. Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome. American Journal of Medical Genetics. Part A. 155: 805-10. PMID 21594999 DOI: 10.1002/Ajmg.A.33917  0.328
2011 Harvey PD, Raykov T, Twamley EW, Vella L, Heaton RK, Patterson TL. Validating the measurement of real-world functional outcomes: phase I results of the VALERO study. The American Journal of Psychiatry. 168: 1195-201. PMID 21572166 DOI: 10.1176/Appi.Ajp.2011.10121723  0.722
2011 Friedman JI, Lindenmayer JP, Alcantara F, Bowler S, Parak M, White L, Iskander A, Parrella M, Adler DN, Tsopelas ND, Tsai WY, Novakovic V, Novakovick V, Harvey PD, Davis KL, et al. Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1289-95. PMID 21346734 DOI: 10.1038/Npp.2011.14  0.41
2011 McIntosh BJ, Zhang XY, Kosten T, Tan SP, Xiu MH, Rakofsky J, Harvey PD. Performance-based assessment of functional skills in severe mental illness: Results of a large-scale study in China Journal of Psychiatric Research. 45: 1089-1094. PMID 21300378 DOI: 10.1016/J.Jpsychires.2011.01.012  0.472
2011 Green MF, Schooler NR, Kern RS, Frese FJ, Granberry W, Harvey PD, Karson CN, Peters N, Stewart M, Seidman LJ, Sonnenberg J, Stone WS, Walling D, Stover E, Marder SR. Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. The American Journal of Psychiatry. 168: 400-7. PMID 21285142 DOI: 10.1176/Appi.Ajp.2010.10030414  0.544
2011 Harvey PD, Ogasa M, Cucchiaro J, Loebel A, Keefe RS. Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. Schizophrenia Research. 127: 188-94. PMID 21277745 DOI: 10.1016/J.Schres.2011.01.004  0.643
2011 Leifker FR, Patterson TL, Heaton RK, Harvey PD. Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophrenia Bulletin. 37: 334-43. PMID 19525354 DOI: 10.1093/Schbul/Sbp044  0.696
2011 Harvey PD. Cognition and the differential diagnosis of schizophrenia. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 30-2. PMID 18458775 DOI: 10.1002/J.2051-5545.2008.Tb00144.X  0.574
2011 Friedman JI, Lindenmayer J, Alcantara F, Bowler S, Parak M, White L, Iskander A, Parrella M, Adler DN, Tsopelas ND, Tsai W, Novakovick V, Harvey PD, Davis KL. Erratum: Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy Neuropsychopharmacology. 36: 2150-2150. DOI: 10.1038/npp.2011.68  0.362
2011 Friedman JI, Lindenmayer J, Alcantara F, Bowler S, Parak M, White L, Iskander A, Parrella M, Adler DN, Tsopelas ND, Tsai W, Novakovick V, Harvey PD, Davis KL. Erratum: Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy Neuropsychopharmacology. 36: 1317-1317. DOI: 10.1038/npp.2011.46  0.362
2010 Depp CA, Mausbach BT, Harvey PD, Bowie CR, Wolyniec PS, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Patterson TL. Social competence and observer-rated social functioning in bipolar disorder. Bipolar Disorders. 12: 843-50. PMID 21176031 DOI: 10.1111/J.1399-5618.2010.00880.X  0.765
2010 Keefe RS, Fox KH, Harvey PD, Cucchiaro J, Siu C, Loebel A. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophrenia Research. 125: 161-8. PMID 21075600 DOI: 10.1016/J.Schres.2010.09.015  0.661
2010 Potkin SG, Preda A, Kalali AH, Harvey PD. Academic Highlights: Challenges and Solutions in Developing New Medications for Schizophrenia The Journal of Clinical Psychiatry. 71: 1391-1399. PMID 21062617 DOI: 10.4088/Jcp.10064Ah1Yel  0.386
2010 Lamonica HM, Keefe RS, Harvey PD, Gold JM, Goldberg TE. Differential effects of emotional information on interference task performance across the life span. Frontiers in Aging Neuroscience. 2. PMID 20953250 DOI: 10.3389/Fnagi.2010.00141  0.451
2010 Harvey PD, Wingo AP, Burdick KE, Baldessarini RJ. Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disorders. 12: 364-75. PMID 20636633 DOI: 10.1111/J.1399-5618.2010.00831.X  0.57
2010 Friedman JI, Wallenstein S, Moshier E, Parrella M, White L, Bowler S, Gottlieb S, Harvey PD, McGinn TG, Flanagan L, Davis KL. The effects of hypertension and body mass index on cognition in schizophrenia. The American Journal of Psychiatry. 167: 1232-9. PMID 20634363 DOI: 10.1176/Appi.Ajp.2010.09091328  0.523
2010 Look AE, Flory JD, Harvey PD, Siever LJ. Psychometric properties of a short form of the Affective Lability Scale (ALS-18). Personality and Individual Differences. 49: 187-191. PMID 20606710 DOI: 10.1016/J.Paid.2010.03.030  0.302
2010 Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial. Journal of Clinical Psychopharmacology. 30: 425-30. PMID 20571437 DOI: 10.1097/Jcp.0B013E3181E69042  0.394
2010 Wingo AP, Baldessarini RJ, Holtzheimer PE, Harvey PD. Factors associated with functional recovery in bipolar disorder patients. Bipolar Disorders. 12: 319-26. PMID 20565439 DOI: 10.1111/J.1399-5618.2010.00808.X  0.355
2010 Bowie CR, Depp C, McGrath JA, Wolyniec P, Mausbach BT, Thornquist MH, Luke J, Patterson TL, Harvey PD, Pulver AE. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. The American Journal of Psychiatry. 167: 1116-24. PMID 20478878 DOI: 10.1176/Appi.Ajp.2010.09101406  0.786
2010 Leifker FR, Patterson TL, Bowie CR, Mausbach BT, Harvey PD. Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change. Schizophrenia Research. 119: 246-52. PMID 20399613 DOI: 10.1016/J.Schres.2010.03.021  0.753
2010 Wingo AP, Baldessarini RJ, Compton MT, Harvey PD. Correlates of recovery of social functioning in types I and II bipolar disorder patients Psychiatry Research. 177: 131-134. PMID 20334933 DOI: 10.1016/J.Psychres.2010.02.020  0.406
2010 Harvey PD, Reichenberg A, Bowie CR, Patterson TL, Heaton RK. The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay. Biological Psychiatry. 67: 933-9. PMID 20202624 DOI: 10.1016/J.Biopsych.2010.01.008  0.805
2010 Mausbach BT, Harvey PD, Pulver AE, Depp CA, Wolyniec PS, Thornquist MH, Luke JR, McGrath JA, Bowie CR, Patterson TL. Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder. Bipolar Disorders. 12: 45-55. PMID 20148866 DOI: 10.1111/J.1399-5618.2009.00787.X  0.804
2010 McClure MM, Harvey PD, Goodman M, Triebwasser J, New A, Koenigsberg HW, Sprung LJ, Flory JD, Siever LJ. Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1356-62. PMID 20130535 DOI: 10.1038/Npp.2010.5  0.754
2010 Goldberg TE, Keefe RS, Goldman RS, Robinson DG, Harvey PD. Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1053-62. PMID 20090669 DOI: 10.1038/Npp.2009.211  0.62
2010 Rapp MA, Schnaider-Beeri M, Purohit DP, Reichenberg A, McGurk SR, Haroutunian V, Harvey PD. Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients. Schizophrenia Research. 116: 90-6. PMID 19896333 DOI: 10.1016/J.Schres.2009.10.013  0.388
2010 Harvey PD, Ferris SH, Cummings JL, Wesnes KA, Hsu C, Lane RM, Tekin S. Evaluation of dementia rating scales in Parkinson's disease dementia. American Journal of Alzheimer's Disease and Other Dementias. 25: 142-8. PMID 19359706 DOI: 10.1177/1533317509333904  0.345
2010 Harvey PD. Cognitive Functioning and Disability in Schizophrenia Current Directions in Psychological Science. 19: 249-254. DOI: 10.1177/0963721410378033  0.532
2010 Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey P, Loebel A, Watsky E, Vanderburg D, Siu C, Romano S. Symptomatic And Functional Recovery Index For Negative Symptoms In A 40-Week Randomized, Double-Blind Study Of Ziprasidone Versus Haloperidol Followed By A 3-Year Double-Blind Extension Trial Schizophrenia Research. 117: 502-502. DOI: 10.1016/J.Schres.2010.02.956  0.305
2010 Bowie CR, Harvey PD, McGrath J, Pulver A. PREDICTORS OF REAL WORLD FUNCTIONAL BEHAVIOR IN BIPOLAR DISORDER AND SCHIZOPHRENIA Schizophrenia Research. 117: 280. DOI: 10.1016/J.Schres.2010.02.456  0.647
2009 Leifker FR, Bowie CR, Harvey PD. Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophrenia Research. 115: 82-7. PMID 19775869 DOI: 10.1016/J.Schres.2009.09.004  0.68
2009 Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. The Journal of Clinical Psychiatry. 70: 1588-97. PMID 19689922 DOI: 10.4088/Jcp.08R04972  0.447
2009 Yehuda R, Harvey PD, Golier JA, Newmark RE, Bowie CR, Wohltmann JJ, Grossman RA, Schmeidler J, Hazlett EA, Buchsbaum MS. Changes in relative glucose metabolic rate following cortisol administration in aging veterans with posttraumatic stress disorder: an FDG-PET neuroimaging study. The Journal of Neuropsychiatry and Clinical Neurosciences. 21: 132-43. PMID 19622684 DOI: 10.1176/Appi.Neuropsych.21.2.132  0.504
2009 Harvey PD, Endicott JM, Loebel AD. The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment. Bipolar Disorders. 10: 900-6. PMID 19594505 DOI: 10.1111/J.1399-5618.2008.00634.X  0.429
2009 McClure MM, Koenigsberg HW, Reynolds D, Goodman M, New A, Trestman R, Silverman J, Harvey PD, Siever LJ. The effects of risperidone on the cognitive performance of individuals with schizotypal personality disorder. Journal of Clinical Psychopharmacology. 29: 396-8. PMID 19593186 DOI: 10.1097/Jcp.0B013E3181Accfd9  0.697
2009 Harvey PD. Pharmacological cognitive enhancement in schizophrenia. Neuropsychology Review. 19: 324-35. PMID 19507034 DOI: 10.1007/S11065-009-9103-4  0.534
2009 Harvey PD, Helldin L, Bowie CR, Heaton RK, Olsson AK, Hjärthag F, Norlander T, Patterson TL. Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. The American Journal of Psychiatry. 166: 821-7. PMID 19487393 DOI: 10.1176/Appi.Ajp.2009.09010106  0.789
2009 Eisenberg DP, Aniskin DB, White L, Stein JA, Harvey PD, Galynker II. Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale. Psychopathology. 42: 242-8. PMID 19451757 DOI: 10.1159/000218522  0.329
2009 Ghaemi SN, Gilmer WS, Dunn RT, Hanlon RE, Kemp DE, Bauer AD, Chriki L, Filkowski MM, Harvey PD. A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder. Journal of Clinical Psychopharmacology. 29: 291-5. PMID 19440086 DOI: 10.1097/Jcp.0B013E3181A497D7  0.467
2009 Harvey PD, Young KP, Reichenberg A, Pogge DL. The factor structure of clinical symptoms in depressed inpatients with unipolar or bipolar spectrum disorders: a preliminary study. The Journal of Nervous and Mental Disease. 197: 161-5. PMID 19282681 DOI: 10.1097/Nmd.0B013E318199Fbbf  0.33
2009 Wingo AP, Harvey PD, Baldessarini RJ. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disorders. 11: 113-25. PMID 19267694 DOI: 10.1111/J.1399-5618.2009.00665.X  0.435
2009 Harvey PD. Functional recovery in schizophrenia: raising the bar for outcomes in people with schizophrenia. Schizophrenia Bulletin. 35: 299. PMID 19244591 DOI: 10.1093/Schbul/Sbn186  0.493
2009 Chemerinski E, Bowie C, Anderson H, Harvey PD. Depression in schizophrenia: methodological artifact or distinct feature of the illness? The Journal of Neuropsychiatry and Clinical Neurosciences. 20: 431-40. PMID 19196927 DOI: 10.1176/Appi.Neuropsych.20.4.431  0.615
2009 Harvey PD, Pappadopulos E, Lombardo I, Kremer CM. Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol. Schizophrenia Research. 115: 24-9. PMID 19189878 DOI: 10.1016/J.Schres.2009.01.004  0.406
2009 Harvey PD, Bellack AS. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? Schizophrenia Bulletin. 35: 300-6. PMID 19126634 DOI: 10.1093/Schbul/Sbn171  0.504
2009 Harvey PD, Cavallaro R. Meeting report: The Emory University-San Raffaele cognition satellite meeting. Schizophrenia Research. 113: 347-50. PMID 19064313 DOI: 10.1016/J.Schres.2008.11.005  0.387
2009 Kleinman L, Lieberman J, Dube S, Mohs R, Zhao Y, Kinon B, Carpenter W, Harvey PD, Green MF, Keefe RS, Frank L, Bowman L, Revicki DA. Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. Schizophrenia Research. 107: 275-85. PMID 19013769 DOI: 10.1016/J.Schres.2008.10.002  0.635
2009 Harvey PD, Keefe RS, Patterson TL, Heaton RK, Bowie CR. Abbreviated neuropsychological assessment in schizophrenia: prediction of different aspects of outcome. Journal of Clinical and Experimental Neuropsychology. 31: 462-71. PMID 18720182 DOI: 10.1080/13803390802251386  0.798
2009 Dickinson D, Harvey PD. Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophrenia Bulletin. 35: 403-14. PMID 18689868 DOI: 10.1093/Schbul/Sbn097  0.505
2009 Reichenberg A, Harvey PD, Bowie CR, Mojtabai R, Rabinowitz J, Heaton RK, Bromet E. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia Bulletin. 35: 1022-9. PMID 18495643 DOI: 10.1093/Schbul/Sbn044  0.725
2008 Carpenter DM, Tang CY, Friedman JI, Hof PR, Stewart DG, Buchsbaum MS, Harvey PD, Gorman JG, Davis KL. Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia. Neuroreport. 19: 1369-72. PMID 18766013 DOI: 10.1097/Wnr.0B013E32830Abc35  0.423
2008 Patterson TL, Harvey P. Real-world functioning and self-evaluation of functioning: Brain structure, mood state, functional skills, and mortality American Journal of Geriatric Psychiatry. 16: 617-620. PMID 18669939 DOI: 10.1097/Jgp.0B013E31817F8Cb9  0.626
2008 Serper M, Beech DR, Harvey PD, Dill C. Neuropsychological and symptom predictors of aggression on the psychiatric inpatient service. Journal of Clinical and Experimental Neuropsychology. 30: 700-9. PMID 18608673 DOI: 10.1080/13803390701684554  0.683
2008 Bowie CR, Harvey PD. Communication abnormalities predict functional outcomes in chronic schizophrenia: differential associations with social and adaptive functions. Schizophrenia Research. 103: 240-7. PMID 18571378 DOI: 10.1016/J.Schres.2008.05.006  0.646
2008 Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L, Golembo S, Kanellopoulou I, Ng J, Hof PR, Harvey PD, Tsopelas ND, Stewart D, Davis KL. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. The American Journal of Psychiatry. 165: 1024-32. PMID 18558643 DOI: 10.1176/Appi.Ajp.2008.07101640  0.45
2008 Pogge DL, Insalaco B, Bertisch H, Bilginer L, Stokes J, Cornblatt BA, Harvey PD. Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors. Psychiatry Research. 160: 47-54. PMID 18534688 DOI: 10.1016/J.Psychres.2007.06.024  0.466
2008 Keefe RSE, Harvey PD. Implementation considerations for multisite clinical trials with cognitive neuroscience tasks Schizophrenia Bulletin. 34: 656-663. PMID 18495645 DOI: 10.1093/Schbul/Sbn042  0.547
2008 Keefe RSE, Harvey PD, Goldberg TE, Gold JM, Walker TM, Kennel C, Hawkins K. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) Schizophrenia Research. 102: 108-115. PMID 18495435 DOI: 10.1016/J.Schres.2008.03.024  0.678
2008 McClure MM, Barch DM, Flory JD, Harvey PD, Siever LJ. Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum. Journal of Abnormal Psychology. 117: 342-54. PMID 18489210 DOI: 10.1037/0021-843X.117.2.342  0.734
2008 Leung WW, Bowie CR, Harvey PD. Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study. Journal of the International Neuropsychological Society : Jins. 14: 479-88. PMID 18419846 DOI: 10.1017/S1355617708080600  0.788
2008 Harvey PD. Introduction to the special section: The Eighth Biennial Mt. Sinai Conference on Cognition in Schizophrenia. Schizophrenia Research. 106: 1-2. PMID 18378429 DOI: 10.1016/J.Schres.2008.02.006  0.509
2008 Harvey PD, Cornblatt BA. Pharmacological treatment of cognition in schizophrenia: an idea whose method has come. The American Journal of Psychiatry. 165: 163-5. PMID 18245181 DOI: 10.1176/Appi.Ajp.2007.07111810  0.518
2008 Harvey PD. The broad importance of cognitive impairments in aging-related disorders. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 99-101. PMID 18239194 DOI: 10.1097/Jgp.0B013E318160F7F1  0.47
2008 Friedman JI, Carpenter D, Lu J, Fan J, Tang CY, White L, Parrella M, Bowler S, Elbaz Z, Flanagan L, Harvey PD. A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia. Journal of Clinical Psychopharmacology. 28: 59-63. PMID 18204342 DOI: 10.1097/Jcp.0B013E318161318F  0.525
2008 O'Halloran JP, Kemp AS, Gooch KN, Harvey PD, Palmer BW, Reist C, Schneider LS. Psychometric comparison of computerized and standard administration of the neurocognitive assessment instruments selected by the CATIE and MATRICS consortia among patients with schizophrenia. Schizophrenia Research. 106: 33-41. PMID 18160262 DOI: 10.1016/J.Schres.2007.11.015  0.389
2008 Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR. Is schizophrenia a syndrome of accelerated aging? Schizophrenia Bulletin. 34: 1024-32. PMID 18156637 DOI: 10.1093/Schbul/Sbm140  0.644
2008 Harvey PD, Sacchetti E, Galluzzo A, Romeo F, Gorini B, Bilder RM, Loebel AD. A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment. Schizophrenia Research. 105: 138-43. PMID 18077136 DOI: 10.1016/J.Schres.2007.11.014  0.514
2008 Bowie CR, Reichenberg A, McClure MM, Leung WL, Harvey PD. Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: differential sensitivity of clinical neuropsychological and experimental information processing tests. Schizophrenia Research. 106: 50-8. PMID 18053687 DOI: 10.1016/J.Schres.2007.10.026  0.81
2008 Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biological Psychiatry. 63: 505-11. PMID 17662256 DOI: 10.1016/J.Biopsych.2007.05.022  0.819
2008 Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste DV, Patterson TL. Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. Journal of Psychiatric Research. 42: 320-7. PMID 17303168 DOI: 10.1016/J.Jpsychires.2006.12.008  0.748
2008 Harvey P. Cognitive Impairment In Schizophrenia Schizophrenia Research. 102: 25. DOI: 10.1016/S0920-9964(08)70077-X  0.547
2008 Harvey P, Kremer C, Lombardo I. 320 – Improvements in everyday functioning with atypical antipsychotic treatment: A randomized long-term comparison of ziprasidone and haloperidol Schizophrenia Research. 98: 165. DOI: 10.1016/J.Schres.2007.12.387  0.306
2007 Leung WW, McClure MM, Siever LJ, Barch DM, Harvey PD. Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions. Neuropsychiatric Disease and Treatment. 3: 925-34. PMID 19300629 DOI: 10.2147/Ndt.S1500  0.788
2007 Harvey PD. Managing cognitive deficits and functioning in patients with schizophrenia. The Journal of Clinical Psychiatry. 68: e21. PMID 17915967 DOI: 10.4088/Jcp.0907E21  0.54
2007 Harvey PD, Hassman H, Mao L, Gharabawi GM, Mahmoud RA, Engelhart LM. Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study. The Journal of Clinical Psychiatry. 68: 1186-94. PMID 17854242 DOI: 10.4088/Jcp.V68N0804  0.463
2007 Reichenberg A, Harvey PD. Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychological Bulletin. 133: 833-58. PMID 17723032 DOI: 10.1037/0033-2909.133.5.833  0.55
2007 Lindenmayer JP, Harvey PD, Khan A, Kirkpatrick B. Schizophrenia: measurements of psychopathology. The Psychiatric Clinics of North America. 30: 339-63. PMID 17720027 DOI: 10.1016/J.Psc.2007.04.005  0.498
2007 Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry. 64: 633-47. PMID 17548746 DOI: 10.1001/Archpsyc.64.6.633  0.578
2007 Pogge DL, Young K, Insalaco B, Harvey PD. Use of atypical antipsychotic medications in adolescent psychiatric inpatients: A comparison with inpatients who did not receive antipsychotic medications during their stay International Journal of Clinical Practice. 61: 896-902. PMID 17504351 DOI: 10.1111/J.1742-1241.2007.01379.X  0.33
2007 Buckley PF, Harvey PD, Bowie CR, Loebel A. The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophrenia Research. 94: 99-106. PMID 17499480 DOI: 10.1016/J.Schres.2006.12.032  0.689
2007 Harvey PD, Velligan DI, Bellack AS. Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophrenia Bulletin. 33: 1138-48. PMID 17493956 DOI: 10.1093/Schbul/Sbm040  0.429
2007 Silverstein JH, Steinmetz J, Reichenberg A, Harvey PD, Rasmussen LS. Postoperative cognitive dysfunction in patients with preoperative cognitive impairment: which domains are most vulnerable? Anesthesiology. 106: 431-5. PMID 17325500 DOI: 10.1097/00000542-200703000-00006  0.433
2007 Pandina GJ, Bilder R, Harvey PD, Keefe RSE, Aman MG, Gharabawi G. Risperidone and Cognitive Function in Children With Disruptive Behavior Disorders Biological Psychiatry. 62: 226-234. PMID 17210137 DOI: 10.1016/J.Biopsych.2006.09.036  0.566
2007 McClure MM, Romero MJ, Bowie CR, Reichenberg A, Harvey PD, Siever LJ. Visual-spatial learning and memory in schizotypal personality disorder: continued evidence for the importance of working memory in the schizophrenia spectrum. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 22: 109-16. PMID 17161580 DOI: 10.1016/J.Acn.2006.11.004  0.723
2007 Harvey PD. Outcomes to monitor when treating bipolar disorder or schizophrenia. The Journal of Clinical Psychiatry. 67: e06. PMID 17107269 DOI: 10.4088/Jcp.0806E06  0.466
2007 Harvey PD. Cognitive and functional effects of atypical antipsychotic medications. The Journal of Clinical Psychiatry. 67: e13. PMID 17107236 DOI: 10.4088/Jcp.1006E13  0.503
2007 Bowie CR, Twamley EW, Anderson H, Halpern B, Patterson TL, Harvey PD. Self-assessment of functional status in schizophrenia. Journal of Psychiatric Research. 41: 1012-8. PMID 17014866 DOI: 10.1016/J.Jpsychires.2006.08.003  0.763
2007 McClure MM, Bowie CR, Patterson TL, Heaton RK, Weaver C, Anderson H, Harvey PD. Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships? Schizophrenia Research. 89: 330-8. PMID 16982175 DOI: 10.1016/J.Schres.2006.07.024  0.844
2007 McClure MM, Barch DM, Romero MJ, Minzenberg MJ, Triebwasser J, Harvey PD, Siever LJ. The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biological Psychiatry. 61: 1157-60. PMID 16950221 DOI: 10.1016/J.Biopsych.2006.06.034  0.754
2007 Bellack AS, Green MF, Cook JA, Fenton W, Harvey PD, Heaton RK, Laughren T, Leon AC, Mayo DJ, Patrick DL, Patterson TL, Rose A, Stover E, Wykes T. Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophrenia Bulletin. 33: 805-22. PMID 16931542 DOI: 10.1093/Schbul/Sbl035  0.683
2007 McClure MM, Harvey PD. Critical issues in the assessment of disability in schizophrenia Clinical Schizophrenia and Related Psychoses. 1: 147-153. DOI: 10.3371/Csrp.1.2.3  0.734
2007 Harvey P, Warrington L, Loebel A, Romeo F, Gorini B, Galluzzo A, Sachetti E. P.3.c.026 Cognitive effects of ziprasidone and clozapine: results from an 18-week double-blind trial European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70663-6  0.352
2006 Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatric Disease and Treatment. 2: 531-6. PMID 19412501 DOI: 10.2147/Nedt.2006.2.4.531  0.711
2006 Harvey PD, Reichenberg A, Bowie CR. Cognition and aging in psychopathology: focus on schizophrenia and depression. Annual Review of Clinical Psychology. 2: 389-409. PMID 17716076 DOI: 10.1146/Annurev.Clinpsy.2.022305.095206  0.663
2006 Bowie CR, Harvey PD. Administration and interpretation of the Trail Making Test. Nature Protocols. 1: 2277-81. PMID 17406468 DOI: 10.1038/Nprot.2006.390  0.602
2006 Harvey PD, Patterson TL, Potter LS, Zhong K, Brecher M. Improvement in social competence with short-term atypical antipsychotic treatment: A randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning American Journal of Psychiatry. 163: 1918-1925. PMID 17074943 DOI: 10.1176/Ajp.2006.163.11.1918  0.649
2006 Yehuda R, Tischler L, Golier JA, Grossman R, Brand SR, Kaufman S, Harvey PD. Longitudinal assessment of cognitive performance in Holocaust survivors with and without PTSD. Biological Psychiatry. 60: 714-21. PMID 17008144 DOI: 10.1016/J.Biopsych.2006.03.069  0.348
2006 Silver JM, Koumaras B, Chen M, Mirski D, Potkin SG, Reyes P, Warden D, Harvey PD, Arciniegas D, Katz DI, Gunay I. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology. 67: 748-55. PMID 16966534 DOI: 10.1212/01.Wnl.0000234062.98062.E9  0.345
2006 White L, Friedman JI, Bowie CR, Evers M, Harvey PD, Parrella M, Mihaila E, Davis KL. Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychotics. Schizophrenia Research. 88: 127-34. PMID 16926093 DOI: 10.1016/J.Schres.2006.06.038  0.685
2006 Harvey PD, McClure MM. Pharmacological approaches to the management of cognitive dysfunction in schizophrenia. Drugs. 66: 1465-73. PMID 16906778 DOI: 10.2165/00003495-200666110-00004  0.762
2006 Golier JA, Harvey PD, Legge J, Yehuda R. Memory performance in older trauma survivors: implications for the longitudinal course of PTSD. Annals of the New York Academy of Sciences. 1071: 54-66. PMID 16891562 DOI: 10.1196/Annals.1364.006  0.318
2006 Harvey PD, Reichenberg A, Romero M, Granholm E, Siever LJ. Dual-task information processing in schizotypal personality disorder: evidence of impaired processing capacity. Neuropsychology. 20: 453-60. PMID 16846263 DOI: 10.1037/0894-4105.20.4.453  0.652
2006 Rabinowitz J, Harvey PD, Eerdekens M, Davidson M. Premorbid functioning and treatment response in recent-onset schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 189: 31-5. PMID 16816303 DOI: 10.1192/Bjp.Bp.105.013276  0.453
2006 Harvey PD, Green MF, Bowie C, Loebel A. The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology. 187: 356-63. PMID 16783539 DOI: 10.1007/S00213-006-0432-1  0.706
2006 Bowie CR, Fallon C, Harvey PD. Convergence of clinical staff ratings and research ratings to assess patients with schizophrenia in nursing homes. Psychiatric Services (Washington, D.C.). 57: 838-43. PMID 16754761 DOI: 10.1176/Appi.Ps.57.6.838  0.595
2006 Minzenberg MJ, Xu K, Mitropoulou V, Harvey PD, Finch T, Flory JD, New AS, Goldman D, Siever LJ. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups. Psychiatric Genetics. 16: 117-24. PMID 16691129 DOI: 10.1097/01.Ypg.0000199448.00163.E6  0.667
2006 Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2033-46. PMID 16641947 DOI: 10.1038/Sj.Npp.1301072  0.658
2006 Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, Knobler HY, Lubin G, Nahon D, Harvey PD, Davidson M. Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: A population-based study Schizophrenia Research. 85: 49-57. PMID 16626941 DOI: 10.1016/J.Schres.2006.03.006  0.492
2006 Chemerinski E, Reichenberg A, Kirkpatrick B, Bowie CR, Harvey PD. Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status. Schizophrenia Research. 85: 12-9. PMID 16624531 DOI: 10.1016/J.Schres.2006.03.002  0.647
2006 Harvey PD, Bowie CR, Loebel A. Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 54-63. PMID 16525071 DOI: 10.1176/Jnp.18.1.54  0.668
2006 Keefe RS, Poe M, Walker TM, Kang JW, Harvey PD. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. The American Journal of Psychiatry. 163: 426-32. PMID 16513863 DOI: 10.1176/Appi.Ajp.163.3.426  0.665
2006 Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. The American Journal of Psychiatry. 163: 418-25. PMID 16513862 DOI: 10.1176/Appi.Ajp.163.3.418  0.788
2006 Keefe RS, Poe M, Walker TM, Harvey PD. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. Journal of Clinical and Experimental Neuropsychology. 28: 260-9. PMID 16484097 DOI: 10.1080/13803390500360539  0.675
2006 Reichenberg A, Weiser M, Caspi A, Knobler HY, Lubin G, Harvey PD, Rabinowitz J, Davidson M. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. Journal of Clinical and Experimental Neuropsychology. 28: 193-207. PMID 16484093 DOI: 10.1080/13803390500360372  0.426
2006 Harvey PD, Friedman JI, Bowie C, Reichenberg A, McGurk SR, Parrella M, White L, Davis KL. Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia. Journal of Clinical and Experimental Neuropsychology. 28: 178-92. PMID 16484092 DOI: 10.1080/13803390500360349  0.688
2006 Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophrenia Bulletin. 32: 250-8. PMID 16221995 DOI: 10.1093/Schbul/Sbj011  0.647
2006 Koren D, Harvey P. Closing the Gap Between Cognitive Performance and Real-World Functional Outcome in Schizophrenia: The Importance of Metacognition Current Psychiatry Reviews. 2: 189-198. DOI: 10.2174/157340006776875950  0.538
2006 Twamley EW, Harvey PD. The importance of cognition in the conceptualization of both dementia and severe mental illness in older people American Journal of Geriatric Psychiatry. 14: 387-390. DOI: 10.1097/01.Jgp.0000220883.94784.Aa  0.546
2006 McClure MM, Zegarelli G, Bowie CR, Mitropoulou V, Siever LJ, Harvey PD. Cognitive impairment in the schizophrenia spectrum: What is the evidence for similarity to schizophrenia? Current Psychosis and Therapeutics Reports. 4: 128-133. DOI: 10.1007/Bf02629335  0.822
2005 Nemeroff CB, Lieberman JA, Weiden PJ, Harvey PD, Newcomer JW, Schatzberg AF, Kilts CD, Daniel DG. From clinical research to clinical practice: a 4-year review of ziprasidone. Cns Spectrums. 10: 1-20. PMID 16381088 DOI: 10.1017/S1092852900019842  0.445
2005 Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, Knobler HY, Lubin G, Nahon D, Harvey PD, Davidson M. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Archives of General Psychiatry. 62: 1297-304. PMID 16330717 DOI: 10.1001/Archpsyc.62.12.1297  0.492
2005 Harvey PD, Moriarty PJ, Kleinman L, Coyne K, Sadowsky CH, Chen M, Mirski DF. The validation of a caregiver assessment of dementia: the Dementia Severity Scale. Alzheimer Disease and Associated Disorders. 19: 186-94. PMID 16327345 DOI: 10.1097/01.Wad.0000189034.43203.60  0.603
2005 Harvey PD, Rabinowitz J, Eerdekens M, Davidson M. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. The American Journal of Psychiatry. 162: 1888-95. PMID 16199835 DOI: 10.1176/APPI.AJP.162.10.1888  0.445
2005 Harvey PD. Conference report: the Seventh Biennial Mt. Sinai Conference on Cognition in Schizophrenia. Schizophrenia Bulletin. 31: 895-7. PMID 16177272 DOI: 10.1093/Schbul/Sbi067  0.548
2005 Bowie CR, Harvey PD. Cognition in schizophrenia: impairments, determinants, and functional importance. The Psychiatric Clinics of North America. 28: 613-33, 626. PMID 16122570 DOI: 10.1016/J.Psc.2005.05.004  0.682
2005 Reichenberg A, Rieckmann N, Harvey PD. Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study. Journal of Abnormal Psychology. 114: 363-72. PMID 16117573 DOI: 10.1037/0021-843X.114.3.363  0.396
2005 Rieckmann N, Reichenberg A, Bowie CR, Parrella M, White L, Friedman JI, Harvey PD. Depressed mood and its functional correlates in institutionalized schizophrenia patients. Schizophrenia Research. 77: 179-87. PMID 15894461 DOI: 10.1016/J.Schres.2005.04.007  0.641
2005 Bowie CR, Serper MR, Riggio S, Harvey PD. Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients. Schizophrenia Bulletin. 31: 175-82. PMID 15888435 DOI: 10.1093/Jschbul/Sbi001  0.798
2005 Friedman JI, Ocampo R, Elbaz Z, Parrella M, White L, Bowler S, Davis KL, Harvey PD. The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia. Journal of Clinical Psychopharmacology. 25: 237-42. PMID 15876902 DOI: 10.1097/01.Jcp.0000161499.58266.51  0.517
2005 Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. The American Journal of Psychiatry. 162: 947-53. PMID 15863797 DOI: 10.1176/Appi.Ajp.162.5.947  0.341
2005 Ginsberg DL, Schooler NR, Buckley PF, Harvey PD, Weiden PJ. Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functioning. Cns Spectrums. 10: 1-13; discussion 14-. PMID 15803622 DOI: 10.1017/S1092852900019337  0.566
2005 Bowie CR, Tsapelas I, Friedman J, Parrella M, White L, Harvey PD. The longitudinal course of thought disorder in geriatric patients with chronic schizophrenia. The American Journal of Psychiatry. 162: 793-5. PMID 15800156 DOI: 10.1176/Appi.Ajp.162.4.793  0.642
2005 Harvey PD, Bowie CR. Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness. Expert Opinion On Pharmacotherapy. 6: 337-46. PMID 15757429 DOI: 10.1517/14656566.6.2.337  0.594
2005 Bilginer L, DeLuca V, Pogge DL, Stokes JS, Harvey PD. Intellectual functioning in adolescents with indicators of psychosis: evidence for decline in functioning related to number of psychotic features? The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 106-13. PMID 15746490 DOI: 10.1176/Jnp.17.1.106  0.436
2005 Weiser M, Kanyas K, Malaspina D, Harvey PD, Glick I, Goetz D, Karni O, Yakir A, Turetsky N, Fennig S, Nahon D, Lerer B, Davidson M. Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Comprehensive Psychiatry. 46: 38-42. PMID 15714193 DOI: 10.1016/J.Comppsych.2004.07.016  0.304
2005 Harvey PD, Palmer BW, Heaton RK, Mohamed S, Kennedy J, Brickman A. Stability of cognitive performance in older patients with schizophrenia: an 8-week test-retest study. The American Journal of Psychiatry. 162: 110-7. PMID 15625208 DOI: 10.1176/Appi.Ajp.162.1.110  0.623
2005 Schimming C, Harvey PD. Disability reduction in elderly patients with schizophrenia. Journal of Psychiatric Practice. 10: 283-95. PMID 15361743 DOI: 10.1097/00131746-200409000-00002  0.506
2005 Mitropoulou V, Harvey PD, Iskander EG, New AS, Silverman JM, Siever LJ. Amphetamine, psychosis, and cognition in the schizophrenia spectrum Current Psychosis & Therapeutics Reports. 3: 176-181. DOI: 10.1007/Bf02629451  0.474
2004 White L, Opler LA, Harvey PD, Parrella M, Friedman JI. Activation symptoms and discharge in elderly chronic schizophrenic inpatients. The Journal of Nervous and Mental Disease. 192: 880-3. PMID 15583513 DOI: 10.1097/01.Nmd.0000146883.74872.07  0.41
2004 Barch DM, Mitropoulou V, Harvey PD, New AS, Silverman JM, Siever LJ. Context-processing deficits in schizotypal personality disorder. Journal of Abnormal Psychology. 113: 556-68. PMID 15535788 DOI: 10.1037/0021-843X.113.4.556  0.495
2004 McGurk SR, Mueser KT, Walling D, Harvey PD, Meltzer HY. Cognitive functioning predicts outpatient service utilization in schizophrenia. Mental Health Services Research. 6: 185-8. PMID 15473104 DOI: 10.1023/B:Mhsr.0000036491.58918.71  0.412
2004 Bowie CR, Reichenberg A, Rieckmann N, Parrella M, White L, Harvey PD. Stability and functional correlates of memory-based classification in older schizophrenia patients. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 12: 376-86. PMID 15249275 DOI: 10.1097/00019442-200407000-00005  0.677
2004 McGurk SR, Coleman T, Harvey PD, Reichenberg A, White L, Friedman J, Parrella M, Davis KL. Working memory performance in poor outcome schizophrenia: relationship to age and executive functioning. Journal of Clinical and Experimental Neuropsychology. 26: 153-60. PMID 15202535 DOI: 10.1076/Jcen.26.2.153.28079  0.394
2004 Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research. 68: 283-97. PMID 15099610 DOI: 10.1016/J.Schres.2003.09.011  0.681
2004 Harvey PD, Green MF, Keefe RS, Velligan DI. Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. The Journal of Clinical Psychiatry. 65: 361-72. PMID 15096076 DOI: 10.4088/Jcp.V65N0312  0.668
2004 Harvey PD, Meltzer H, Simpson GM, Potkin SG, Loebel A, Siu C, Romano SJ. Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia. Schizophrenia Research. 66: 101-13. PMID 15061242 DOI: 10.1016/J.Schres.2003.07.009  0.517
2004 Good KP, Rabinowitz J, Whitehorn D, Harvey PD, DeSmedt G, Kopala LC. The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients. Schizophrenia Research. 68: 11-9. PMID 15037335 DOI: 10.1016/J.Schres.2003.07.001  0.491
2004 Bowie CR, Harvey PD, Moriarty PJ, Parrella M, White L, Davis KL. A comprehensive analysis of verbal fluency deficit in geriatric schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 19: 289-303. PMID 15010092 DOI: 10.1016/S0887-6177(03)00041-6  0.677
2004 Harvey PD. Commentary: Chickens and eggs; carts and horses: an outsider's perspective on the study of the early stages and potential prevention of psychosis and schizophrenia. Schizophrenia Bulletin. 29: 845-9. PMID 14989418 DOI: 10.1093/Oxfordjournals.Schbul.A007050  0.463
2004 Bowie CR, Reichenberg A, Rieckmann N, Parrella M, White L, Harvey PD. Stability and Functional Correlates of Memory-Based Classification in Older Schizophrenia Patients The American Journal of Geriatric Psychiatry. 12: 376-386. DOI: 10.1097/00019442-200407000-00005  0.585
2004 Harvey PD. Multiple Perspectives on Cognition in Schizophrenia Cns Spectrums. 9: 334-334. DOI: 10.1017/S1092852900009305  0.573
2003 Harvey PD, Siu CO, Romano S. Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Psychopharmacology. 172: 324-32. PMID 14615877 DOI: 10.1007/S00213-003-1652-2  0.542
2003 Harvey PD, Bertisch H, Friedman JI, Marcus S, Parrella M, White L, Davis KL. The course of functional decline in geriatric patients with schizophrenia: cognitive-functional and clinical symptoms as determinants of change. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 610-9. PMID 14609801 DOI: 10.1176/Appi.Ajgp.11.6.610  0.531
2003 Harvey PD, Geyer MA, Robbins TW, Krystal JH. Cognition in schizophrenia: from basic science to clinical treatment. Psychopharmacology. 169: 213-4. PMID 12955286 DOI: 10.1007/S00213-003-1581-0  0.558
2003 Harvey PD, Napolitano JA, Mao L, Gharabawi G. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder. International Journal of Geriatric Psychiatry. 18: 820-9. PMID 12949850 DOI: 10.1002/Gps.929  0.556
2003 Moriarty PJ, Harvey PD, Mitropoulou V, Granholm E, Silverman JM, Siever LJ. Reduced processing resource availability in schizotypal personality disorder: evidence from a dual-task CPT study. Journal of Clinical and Experimental Neuropsychology. 25: 335-47. PMID 12916647 DOI: 10.1076/Jcen.25.3.335.13808  0.719
2003 Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophrenia Bulletin. 29: 45-55. PMID 12908660 DOI: 10.1093/Oxfordjournals.Schbul.A006990  0.616
2003 McGurk SR, Mueser KT, Harvey PD, LaPuglia R, Marder J. Cognitive and Symptom Predictors of Work Outcomes for Clients With Schizophrenia in Supported Employment Psychiatric Services. 54: 1129-1135. PMID 12883141 DOI: 10.1176/Appi.Ps.54.8.1129  0.517
2003 Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry. 60: 443-56. PMID 12742865 DOI: 10.1001/Archpsyc.60.5.443  0.381
2003 Harvey PD, Green MF, McGurk SR, Meltzer HY. Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology. 169: 404-11. PMID 12590356 DOI: 10.1007/S00213-002-1342-5  0.506
2003 Rabinowitz J, De Smedt G, Harvey PD, Davidson M. Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. The American Journal of Psychiatry. 159: 2021-6. PMID 12450951 DOI: 10.1176/Appi.Ajp.159.12.2021  0.457
2003 Harvey PD, Artiola i Fortuny L, Vester-Blockland E, De Smedt G. Cross-national cognitive assessment in schizophrenia clinical trials: a feasibility study. Schizophrenia Research. 59: 243-51. PMID 12414081 DOI: 10.1016/S0920-9964(02)00153-6  0.413
2003 Harvey PD, Bertisch H, Friedman JI, Marcus S, Parrella M, White L, Davis KL. The Course of Functional Decline in Geriatric Patients With Schizophrenia American Journal of Geriatric Psychiatry. 11: 610-619. DOI: 10.1097/00019442-200311000-00005  0.399
2003 Harvey PD, Bowie CR. Cognitive deficits in schizophrenia: Early course and treatment Clinical Neuroscience Research. 3: 17-22. DOI: 10.1016/S1566-2772(03)00015-X  0.71
2003 Harvey P, Bertisch H, Friedman J, Parrella M, White L, Davis K. Cognitive and functional changes in older patients with schizophrenia: Evidence for cognitive threshold effects on functional decline? Schizophrenia Research. 60: 137-138. DOI: 10.1016/S0920-9964(03)80935-0  0.433
2003 Bowie C, Serper M, Harvey P. Neurocognition, symptomatology, and social-adaptive functioning in alcohol-abusing schizophrenia patients Schizophrenia Research. 60: 126. DOI: 10.1016/S0920-9964(03)80900-3  0.766
2003 Galynker I, White L, Milak M, Prinkhojan A, Stein J, Harvey P. An empirical study of the factor structure of negative symptoms and dysphoric mood in schizophrenia, dementia and depression Schizophrenia Research. 60: 16. DOI: 10.1016/S0920-9964(03)80044-0  0.422
2003 Harvey PD, Bowie CR. Cognitive functioning in schizophrenia Current Psychosis & Therapeutics Reports. 1: 22-27. DOI: 10.1007/Bf02629435  0.721
2002 Bowie CR, Harvey PD, Moriarty PJ, Parrella M, White L, Mohs RC, Davis KL. Cognitive assessment of geriatric schizophrenic patients with severe impairment. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 17: 611-23. PMID 14591846 DOI: 10.1016/S0887-6177(01)00165-2  0.752
2002 Friedman JI, Harvey PD, McGurk SR, White L, Parrella M, Raykov T, Coleman T, Adler DN, Davis KL. Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity. The American Journal of Psychiatry. 159: 1388-94. PMID 12153833 DOI: 10.1176/Appi.Ajp.159.8.1388  0.507
2002 Harvey PD, Moriarty PJ, Bowie C, Friedman JI, Parrella M, White L, Davis KL. Cortical and subcortical cognitive deficits in schizophrenia: convergence of classifications based on language and memory skill areas. Journal of Clinical and Experimental Neuropsychology. 24: 55-66. PMID 11935424 DOI: 10.1076/Jcen.24.1.55.964  0.747
2002 Friedman JI, Adler DN, Howanitz E, Harvey PD, Brenner G, Temporini H, White L, Parrella M, Davis KL. A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biological Psychiatry. 51: 349-57. PMID 11904128 DOI: 10.1016/S0006-3223(01)01342-7  0.547
2002 Siever LJ, Koenigsberg HW, Harvey P, Mitropoulou V, Laruelle M, Abi-Dargham A, Goodman M, Buchsbaum M. Cognitive and brain function in schizotypal personality disorder. Schizophrenia Research. 54: 157-67. PMID 11853990 DOI: 10.1016/S0920-9964(01)00363-2  0.501
2002 Harvey PD. Cognitive impairment in elderly patients with schizophrenia: age related changes. International Journal of Geriatric Psychiatry. S78-85. PMID 11748791 DOI: 10.1002/1099-1166(200112)16:1+<::Aid-Gps565>3.0.Co;2-V  0.548
2002 Koenigsberg HW, Harvey PD, Mitropoulou V, New AS, Goodman M, Silverman J, Serby M, Schopick F, Siever LJ. Are the interpersonal and identity disturbances in the borderline personality disorder criteria linked to the traits of affective instability and impulsivity? Journal of Personality Disorders. 15: 358-70. PMID 11556702 DOI: 10.1521/Pedi.15.4.358.19181  0.302
2002 Harvey P, Simpson G, Horne R, Weiden P, Bari M, Romano S. Ziprasidone vs olanzapine for cognitive function in schizophrenia European Psychiatry. 17: 100. DOI: 10.1016/S0924-977X(02)80420-5  0.556
2002 Harvey P, Mao L, Napolitano J, Gharabawi G. Cognition in elderly schizophrenic patients: risperidone vs olanzapine European Psychiatry. 17: 192. DOI: 10.1016/S0924-9338(02)80823-9  0.442
2002 Harvey P, Meltzer H, Romano S. Cognitive function in stable outpatients switched to ziprasidone European Psychiatry. 17: 99-100. DOI: 10.1016/S0924-9338(02)80451-5  0.417
2001 Vadhan NP, Serper MR, Harvey PD, Chou JC, Cancro R. Convergent validity and neuropsychological correlates of the schedule for the assessment of negative symptoms (SANS) attention subscale. The Journal of Nervous and Mental Disease. 189: 637-41. PMID 11580009 DOI: 10.1097/00005053-200109000-00011  0.834
2001 Harvey PD, Bowie CR, Friedman JI. Cognition in schizophrenia. Current Psychiatry Reports. 3: 423-8. PMID 11559481 DOI: 10.1007/S11920-996-0038-7  0.71
2001 Friedman JI, Harvey PD, Coleman T, Moriarty PJ, Bowie C, Parrella M, White L, Adler D, Davis KL. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. The American Journal of Psychiatry. 158: 1441-8. PMID 11532729 DOI: 10.1176/Appi.Ajp.158.9.1441  0.678
2001 Friedman JI, Adler DN, Temporini HD, Kemether E, Harvey PD, White L, Parrella M, Davis KL. Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 402-9. PMID 11522468 DOI: 10.1016/S0893-133X(01)00249-4  0.414
2001 Bowie CR, Moriarty PJ, Harvey PD, Parrella M, White L, Davis KL. Aggression in elderly schizophrenia patients: a comparison of nursing home and state hospital residents. The Journal of Neuropsychiatry and Clinical Neurosciences. 13: 357-66. PMID 11514642 DOI: 10.1176/Jnp.13.3.357  0.616
2001 Harvey PD, Serper MR, White L, Parrella MJ, McGurk SR, Moriarty PJ, Bowie C, Vadhan N, Friedman J, Davis KL. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Comprehensive Psychiatry. 42: 306-13. PMID 11458305 DOI: 10.1053/Comp.2001.24587A  0.854
2001 Harvey PD. Cognitive and functional impairments in elderly patients with schizophrenia: a review of the recent literature. Harvard Review of Psychiatry. 9: 59-68. PMID 11266403 DOI: 10.1080/10673220127879  0.559
2001 Pogge DL, Wayland-Smith D, Zaccario M, Borgaro S, Stokes J, Harvey PD. Diagnosis of manic episodes in adolescent inpatients: structured diagnostic procedures compared to clinical chart diagnoses. Psychiatry Research. 101: 47-54. PMID 11223119 DOI: 10.1016/S0165-1781(00)00248-1  0.31
2001 Moriarty PJ, Lieber D, Bennett A, White L, Parrella M, Harvey PD, Davis KL. Gender differences in poor outcome patients with lifelong schizophrenia. Schizophrenia Bulletin. 27: 103-13. PMID 11215540 DOI: 10.1093/Oxfordjournals.Schbul.A006850  0.511
2001 Harvey PD, Keefe RSE. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment American Journal of Psychiatry. 158: 176-184. PMID 11156796 DOI: 10.1176/Appi.Ajp.158.2.176  0.681
2001 Putnam KM, Harvey PD. Cognitive impairment and enduring negative symptoms: a comparative study of geriatric and nongeriatric schizophrenia patients. Schizophrenia Bulletin. 26: 867-78. PMID 11087019 DOI: 10.1093/Oxfordjournals.Schbul.A033501  0.542
2001 Harvey P, Mahmoud R, Meltzer H, Green M. Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder European Neuropsychopharmacology. 11: S257. DOI: 10.1016/S0924-977X(01)80302-3  0.451
2000 Harvey PD, Moriarty PJ, Serper MR, Schnur E, Lieber D. Practice-related improvement in information processing with novel antipsychotic treatment. Schizophrenia Research. 46: 139-48. PMID 11120426 DOI: 10.1016/S0920-9964(00)00033-5  0.717
2000 McGurk SR, Moriarty PJ, Harvey PD, Parrella M, White L, Friedman J, Davis KL. Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients. The Journal of Neuropsychiatry and Clinical Neurosciences. 12: 257-64. PMID 11001606 DOI: 10.1176/Jnp.12.2.257  0.464
2000 Bergman AJ, Silverman JM, Harvey PD, Smith CJ, Siever LJ. Schizotypal symptoms in the relatives of schizophrenia patients: An empirical analysis of the factor structure Schizophrenia Bulletin. 26: 577-586. PMID 10993399 DOI: 10.1093/Oxfordjournals.Schbul.A033479  0.494
2000 Mojtabai R, Bromet EJ, Harvey PD, Carlson GA, Craig TJ, Fennig S. Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders American Journal of Psychiatry. 157: 1453-1460. PMID 10964862 DOI: 10.1176/Appi.Ajp.157.9.1453  0.489
2000 Davidson M, Harvey PD, Vervarcke J, Gagiano CA, De Hooge JD, Bray G, Dose M, Barak Y, Haushofer M. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group. International Journal of Geriatric Psychiatry. 15: 506-14. PMID 10861916 DOI: 10.1002/1099-1166(200006)15:6<506::AID-GPS146>3.0.CO;2-V  0.325
2000 Harvey PD, Moriarty PJ, Friedman JI, White L, Parrella M, Mohs RC, Davis KL. Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areas. Biological Psychiatry. 47: 962-8. PMID 10838064 DOI: 10.1016/S0006-3223(00)00245-6  0.532
2000 Hazlett EA, Buchsbaum MS, Jeu LA, Nenadic I, Fleischman MB, Shihabuddin L, Haznedar MM, Harvey PD. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task. Schizophrenia Research. 43: 33-46. PMID 10828413 DOI: 10.1016/S0920-9964(99)00178-4  0.444
2000 Harvey PD, Jacobsen H, Mancini D, Parrella M, White L, Haroutunian V, Davis KL. Clinical, cognitive and functional characteristics of long-stay patients with schizophrenia: a comparison of VA and state hospital patients. Schizophrenia Research. 43: 3-9. PMID 10828410 DOI: 10.1016/S0920-9964(99)00182-6  0.482
2000 Howanitz E, Cicalese C, Harvey PD. Verbal fluency and psychiatric symptoms in geriatric schizophrenia. Schizophrenia Research. 42: 167-9. PMID 10785575 DOI: 10.1016/S0920-9964(99)00137-1  0.442
2000 Roitman SE, Mitropoulou V, Keefe RS, Silverman JM, Serby M, Harvey PD, Reynolds DA, Mohs RC, Siever LJ. Visuospatial working memory in schizotypal personality disorder patients. Schizophrenia Research. 41: 447-55. PMID 10728721 DOI: 10.1016/S0920-9964(99)00085-7  0.615
2000 McGurk SR, Moriarty PJ, Harvey PD, Parrella M, White L, Davis KL. The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophrenia Research. 42: 47-55. PMID 10706985 DOI: 10.1016/S0920-9964(99)00097-3  0.571
2000 Byne W, Stamu C, White L, Parrella M, Harvey PD, Davis KL. Prevalence and correlates of parkinsonism in an institutionalized population of geriatric patients with chronic schizophrenia. International Journal of Geriatric Psychiatry. 15: 7-13. PMID 10637399 DOI: 10.1002/(Sici)1099-1166(200001)15:1<7::Aid-Gps69>3.0.Co;2-Z  0.402
2000 Kirrane RM, Mitropoulou V, Nunn M, New AS, Harvey PD, Schopick F, Silverman J, Siever LJ. Effects of amphetamine on visuospatial working memory performance in schizophrenia spectrum personality disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 14-8. PMID 10633486 DOI: 10.1016/S0893-133X(99)00075-5  0.364
2000 Harvey PD. Management of Schizophrenia With Cognitive Impairment Psychiatric Annals. 30: 53-58. DOI: 10.3928/0048-5713-20000101-12  0.518
2000 Harvey P, Meltzer H, Romano S. Improvement in cognition following a switch to open-label ziprasidone from olanzapine, risperidone and conventional antipsychotics European Neuropsychopharmacology. 10: 288. DOI: 10.1016/S0924-977X(00)80302-8  0.312
2000 Harvey PD, Green MF. 380. Functional deficit in schizophrenia: course, correlates, and etiological factors Biological Psychiatry. 47: S116. DOI: 10.1016/S0006-3223(00)00644-2  0.487
2000 Bowie C, Moriarty P, Harvey P, Parrella M, White L, Davis K. 149. Verbal and physical aggression in poor outcome, geriatric schizophrenia Biological Psychiatry. 47: S45. DOI: 10.1016/S0006-3223(00)00411-X  0.591
2000 Moriarty P, Coleman T, Friedman J, Harvey P, Bowie C, White L, Parella M, Davis K. 108. Neurocognitive predictors of functional decline in poor-outcome schizophrenia Biological Psychiatry. 47: S33. DOI: 10.1016/S0006-3223(00)00370-X  0.644
1999 Putnam KM, Harvey PD. Memory performance of geriatric and nongeriatric chronic schizophrenic patients: a cross-sectional study. Journal of the International Neuropsychological Society : Jins. 5: 494-501. PMID 10561929 DOI: 10.1017/S1355617799566022  0.394
1999 Friedman JI, Harvey PD, Kemether E, Byne W, Davis KL. Cognitive and functional changes with aging in schizophrenia. Biological Psychiatry. 46: 921-8. PMID 10509175 DOI: 10.1016/S0006-3223(99)00080-3  0.553
1999 Harvey PD, Parrella M, White L, Mohs RC, Davidson M, Davis KL. Convergence of cognitive and adaptive decline in late-life schizophrenia. Schizophrenia Research. 35: 77-84. PMID 9988843 DOI: 10.1016/S0920-9964(98)00109-1  0.569
1999 Harvey PD, Silverman JM, Mohs RC, Parrella M, White L, Powchik P, Davidson M, Davis KL. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry. 45: 32-40. PMID 9894573 DOI: 10.1016/S0006-3223(98)00273-X  0.51
1999 Harvey PD. Cognitive Impairment in Schizophrenia: Its Characteristics and Implications Psychiatric Annals. 29: 657-660. DOI: 10.3928/0048-5713-19991101-12  0.55
1998 Bergman AJ, Harvey PD, Roitman SL, Mohs RC, Marder D, Silverman JM, Siever LJ. Verbal learning and memory in schizotypal personality disorder. Schizophrenia Bulletin. 24: 635-41. PMID 9853795 DOI: 10.1093/Oxfordjournals.Schbul.A033355  0.431
1998 Powchik P, Davidson M, Haroutunian V, Gabriel SM, Purohit DP, Perl DP, Harvey PD, Davis KL. Postmortem studies in schizophrenia. Schizophrenia Bulletin. 24: 325-41. PMID 9718627 DOI: 10.1093/Oxfordjournals.Schbul.A033330  0.543
1998 Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. The American Journal of Psychiatry. 155: 1080-6. PMID 9699697 DOI: 10.1176/Ajp.155.8.1080  0.498
Show low-probability matches.